| Type/Location of Treatment or Other Services | Aged 12-17 (2021) |
Aged 12-17 (2022) |
Aged 12-13 (2021) |
Aged 12-13 (2022) |
Aged 14-15 (2021) |
Aged 14-15 (2022) |
Aged 16-17 (2021) |
Aged 16-17 (2022) |
|---|---|---|---|---|---|---|---|---|
| MENTAL HEALTH TREATMENT OR OTHER SERVICES | -- | 8,200 | -- | 2,697 | -- | 2,991 | -- | 2,513 |
| MENTAL HEALTH TREATMENT | -- | 7,669 | -- | 2,508 | -- | 2,769 | -- | 2,392 |
| Inpatient | -- | 783 | -- | 281 | -- | 278 | -- | 224 |
| Hospital | -- | 551 | -- | 179 | -- | 214 | -- | 158 |
| Residential Mental Health Treatment Center | -- | 394 | -- | 138 | -- | 132 | -- | 124 |
| Residential Drug or Alcohol Rehab or Treatment Center | -- | 69 | -- | 24 | -- | 19 | -- | 26 |
| Some Other Place as an Inpatient | -- | 157 | -- | 65 | -- | 46 | -- | 47 |
| Outpatient | -- | 5,907 | -- | 1,941 | -- | 2,128 | -- | 1,838 |
| Mental Health Treatment Center | -- | 954 | -- | 231 | -- | 357 | -- | 365 |
| Drug or Alcohol Rehab or Treatment Center | -- | 61 | -- | 16 | -- | 14 | -- | 31 |
| Office of a Therapist, Psychologist, Psychiatrist, or Mental Health Professional |
-- | 3,340 | -- | 885 | -- | 1,212 | -- | 1,243 |
| General Medical Clinic or Doctor’s Office | -- | 2,430 | -- | 834 | -- | 811 | -- | 784 |
| Hospital | -- | 504 | -- | 136 | -- | 207 | -- | 160 |
| School’s Health or Counseling Center | -- | 3,135 | -- | 1,140 | -- | 1,108 | -- | 887 |
| Some Other Place as an Outpatient | -- | 194 | -- | 84 | -- | 69 | -- | 41 |
| Outpatient, Other Than General Medical Clinic or Doctor’s Office |
-- | 5,145 | -- | 1,653 | -- | 1,858 | -- | 1,633 |
| Prescription Medication | -- | 3,287 | -- | 1,009 | -- | 1,131 | -- | 1,147 |
| Telehealth Treatment1 | -- | 3,561 | -- | 913 | -- | 1,264 | -- | 1,384 |
| Prison, Jail, or Juvenile Detention Center | -- | 304 | -- | 80 | -- | 145 | -- | 78 |
| OTHER SERVICES | ||||||||
| Support Services | ||||||||
| Support Group | -- | 1,855 | -- | 586 | -- | 755 | -- | 514 |
| Peer Support Specialist or Recovery Coach | -- | 785 | -- | 258 | -- | 315 | -- | 212 |
| Emergency Room/Department | -- | 691 | -- | 235 | -- | 258 | -- | 197 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple types/locations for receiving mental health treatment or other services; thus, these response categories are not mutually exclusive. 1 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Type/Location of Treatment or Other Services | Aged 12-17 (2021) |
Aged 12-17 (2022) |
Aged 12-13 (2021) |
Aged 12-13 (2022) |
Aged 14-15 (2021) |
Aged 14-15 (2022) |
Aged 16-17 (2021) |
Aged 16-17 (2022) |
|---|---|---|---|---|---|---|---|---|
| MENTAL HEALTH TREATMENT OR OTHER SERVICES | -- | 31.9 | -- | 32.0 | -- | 33.0 | -- | 30.6 |
| MENTAL HEALTH TREATMENT | -- | 29.8 | -- | 29.7 | -- | 30.6 | -- | 29.1 |
| Inpatient | -- | 3.0 | -- | 3.3 | -- | 3.1 | -- | 2.7 |
| Hospital | -- | 2.1 | -- | 2.1 | -- | 2.4 | -- | 1.9 |
| Residential Mental Health Treatment Center | -- | 1.5 | -- | 1.6 | -- | 1.5 | -- | 1.5 |
| Residential Drug or Alcohol Rehab or Treatment Center | -- | 0.3 | -- | 0.3 | -- | 0.2 | -- | 0.3 |
| Some Other Place as an Inpatient | -- | 0.6 | -- | 0.8 | -- | 0.5 | -- | 0.6 |
| Outpatient | -- | 23.0 | -- | 23.0 | -- | 23.5 | -- | 22.3 |
| Mental Health Treatment Center | -- | 3.7 | -- | 2.7 | -- | 3.9 | -- | 4.4 |
| Drug or Alcohol Rehab or Treatment Center | -- | 0.2 | -- | 0.2 | -- | 0.2 | -- | 0.4 |
| Office of a Therapist, Psychologist, Psychiatrist, or Mental Health Professional |
-- | 13.0 | -- | 10.5 | -- | 13.4 | -- | 15.1 |
| General Medical Clinic or Doctor’s Office | -- | 9.4 | -- | 9.9 | -- | 8.9 | -- | 9.5 |
| Hospital | -- | 2.0 | -- | 1.6 | -- | 2.3 | -- | 1.9 |
| School’s Health or Counseling Center | -- | 12.2 | -- | 13.5 | -- | 12.2 | -- | 10.8 |
| Some Other Place as an Outpatient | -- | 0.8 | -- | 1.0 | -- | 0.8 | -- | 0.5 |
| Outpatient, Other Than General Medical Clinic or Doctor’s Office |
-- | 20.0 | -- | 19.6 | -- | 20.5 | -- | 19.9 |
| Prescription Medication | -- | 12.8 | -- | 12.0 | -- | 12.5 | -- | 14.0 |
| Telehealth Treatment1 | -- | 13.8 | -- | 10.8 | -- | 14.0 | -- | 16.8 |
| Prison, Jail, or Juvenile Detention Center | -- | 1.2 | -- | 0.9 | -- | 1.6 | -- | 1.0 |
| OTHER SERVICES | ||||||||
| Support Services | ||||||||
| Support Group | -- | 7.2 | -- | 6.9 | -- | 8.3 | -- | 6.3 |
| Peer Support Specialist or Recovery Coach | -- | 3.1 | -- | 3.1 | -- | 3.5 | -- | 2.6 |
| Emergency Room/Department | -- | 2.7 | -- | 2.8 | -- | 2.9 | -- | 2.4 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple types/locations for receiving mental health treatment or other services; thus, these response categories are not mutually exclusive. 1 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Mental Health Treatment (2021) |
Mental Health Treatment (2022) |
Inpatient (2021) |
Inpatient (2022) |
Outpatient (2021) |
Outpatient (2022) |
Prescription Medication (2021) |
Prescription Medication (2022) |
Telehealth Treatment1 (2021) |
Telehealth Treatment1 (2022) |
Prison, Jail, or Juvenile Detention Center (2021) |
Prison, Jail, or Juvenile Detention Center (2022) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 7,669 | -- | 783 | -- | 5,907 | -- | 3,287 | -- | 3,561 | -- | 304 |
| AGE GROUP | ||||||||||||
| 12-13 | -- | 2,508 | -- | 281 | -- | 1,941 | -- | 1,009 | -- | 913 | -- | 80 |
| 14-15 | -- | 2,769 | -- | 278 | -- | 2,128 | -- | 1,131 | -- | 1,264 | -- | 145 |
| 16-17 | -- | 2,392 | -- | 224 | -- | 1,838 | -- | 1,147 | -- | 1,384 | -- | 78 |
| GENDER | ||||||||||||
| Male | -- | 3,263 | -- | 314 | -- | 2,250 | -- | 1,468 | -- | 1,282 | -- | 133 |
| Female | -- | 4,406 | -- | 469 | -- | 3,658 | -- | 1,819 | -- | 2,279 | -- | 171 |
| HISPANIC ORIGIN AND RACE | ||||||||||||
| Not Hispanic or Latino | -- | 5,829 | -- | 591 | -- | 4,427 | -- | 2,602 | -- | 2,770 | -- | 226 |
| AIAN | -- | * | -- | 13 | -- | 51 | -- | 30 | -- | * | -- | 1 |
| Asian | -- | 326 | -- | 31 | -- | 268 | -- | 69 | -- | 114 | -- | 17 |
| Black or African American | -- | 859 | -- | 168 | -- | 614 | -- | 304 | -- | 295 | -- | 34 |
| NHOPI | -- | * | -- | * | -- | * | -- | * | -- | * | -- | * |
| White | -- | 4,292 | -- | 350 | -- | 3,268 | -- | 2,086 | -- | 2,186 | -- | 156 |
| Two or More Races | -- | 266 | -- | 26 | -- | 216 | -- | 112 | -- | 135 | -- | 18 |
| Hispanic or Latino | -- | 1,840 | -- | 192 | -- | 1,481 | -- | 685 | -- | 791 | -- | 77 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple types/locations for receiving mental health treatment; thus, these response categories are not mutually exclusive. 1 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||||
| Demographic Characteristic | Mental Health Treatment (2021) |
Mental Health Treatment (2022) |
Inpatient (2021) |
Inpatient (2022) |
Outpatient (2021) |
Outpatient (2022) |
Prescription Medication (2021) |
Prescription Medication (2022) |
Telehealth Treatment1 (2021) |
Telehealth Treatment1 (2022) |
Prison, Jail, or Juvenile Detention Center (2021) |
Prison, Jail, or Juvenile Detention Center (2022) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 29.8 | -- | 3.0 | -- | 23.0 | -- | 12.8 | -- | 13.8 | -- | 1.2 |
| AGE GROUP | ||||||||||||
| 12-13 | -- | 29.7 | -- | 3.3 | -- | 23.0 | -- | 12.0 | -- | 10.8 | -- | 0.9 |
| 14-15 | -- | 30.6 | -- | 3.1 | -- | 23.5 | -- | 12.5 | -- | 14.0 | -- | 1.6 |
| 16-17 | -- | 29.1 | -- | 2.7 | -- | 22.3 | -- | 14.0 | -- | 16.8 | -- | 1.0 |
| GENDER | ||||||||||||
| Male | -- | 24.8 | -- | 2.4 | -- | 17.1 | -- | 11.2 | -- | 9.7 | -- | 1.0 |
| Female | -- | 35.1 | -- | 3.7 | -- | 29.1 | -- | 14.5 | -- | 18.1 | -- | 1.4 |
| HISPANIC ORIGIN AND RACE | ||||||||||||
| Not Hispanic or Latino | -- | 30.6 | -- | 3.1 | -- | 23.2 | -- | 13.6 | -- | 14.5 | -- | 1.2 |
| AIAN | -- | * | -- | 5.8 | -- | 23.0 | -- | 13.5 | -- | * | -- | 0.6 |
| Asian | -- | 20.3 | -- | 1.9 | -- | 16.7 | -- | 4.3 | -- | 7.1 | -- | 1.0 |
| Black or African American | -- | 24.5 | -- | 4.8 | -- | 17.5 | -- | 8.7 | -- | 8.4 | -- | 1.0 |
| NHOPI | -- | * | -- | * | -- | * | -- | * | -- | * | -- | * |
| White | -- | 33.4 | -- | 2.7 | -- | 25.4 | -- | 16.2 | -- | 17.0 | -- | 1.2 |
| Two or More Races | -- | 31.9 | -- | 3.2 | -- | 25.9 | -- | 13.5 | -- | 16.2 | -- | 2.2 |
| Hispanic or Latino | -- | 27.7 | -- | 2.9 | -- | 22.3 | -- | 10.3 | -- | 11.9 | -- | 1.2 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple types/locations for receiving mental health treatment; thus, these response categories are not mutually exclusive. 1 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||||
| Geographic/Socioeconomic/ Health Characteristic |
Mental Health Treatment (2021) |
Mental Health Treatment (2022) |
Inpatient (2021) |
Inpatient (2022) |
Outpatient (2021) |
Outpatient (2022) |
Prescription Medication (2021) |
Prescription Medication (2022) |
Telehealth Treatment1 (2021) |
Telehealth Treatment1 (2022) |
Prison, Jail, or Juvenile Detention Center (2021) |
Prison, Jail, or Juvenile Detention Center (2022) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 7,669 | -- | 783 | -- | 5,907 | -- | 3,287 | -- | 3,561 | -- | 304 |
| GEOGRAPHIC REGION | ||||||||||||
| Northeast | -- | 1,257 | -- | 130 | -- | 1,020 | -- | 447 | -- | 671 | -- | 46 |
| Midwest | -- | 1,706 | -- | 151 | -- | 1,305 | -- | 771 | -- | 744 | -- | 70 |
| South | -- | 2,914 | -- | 348 | -- | 2,173 | -- | 1,379 | -- | 1,224 | -- | 96 |
| West | -- | 1,792 | -- | 153 | -- | 1,409 | -- | 690 | -- | 922 | -- | 91 |
| COUNTY TYPE | ||||||||||||
| Large Metro | -- | 4,355 | -- | 422 | -- | 3,395 | -- | 1,760 | -- | 2,076 | -- | 159 |
| Small Metro | -- | 2,475 | -- | 269 | -- | 1,880 | -- | 1,123 | -- | 1,150 | -- | 104 |
| Nonmetro | -- | 839 | -- | 92 | -- | 633 | -- | 405 | -- | 336 | -- | 41 |
| Urbanized | -- | 385 | -- | 41 | -- | 296 | -- | 173 | -- | 171 | -- | 27 |
| Less Urbanized | -- | 402 | -- | 27 | -- | 295 | -- | 206 | -- | 144 | -- | 12 |
| Completely Rural | -- | * | -- | * | -- | * | -- | 25 | -- | 21 | -- | 2 |
| POVERTY LEVEL | ||||||||||||
| Less Than 100% | -- | 1,321 | -- | 218 | -- | 980 | -- | 516 | -- | 528 | -- | 82 |
| 100-199% | -- | 1,734 | -- | 196 | -- | 1,320 | -- | 735 | -- | 705 | -- | 56 |
| 200% or More | -- | 4,614 | -- | 369 | -- | 3,607 | -- | 2,036 | -- | 2,328 | -- | 166 |
| HEALTH INSURANCE2 | ||||||||||||
| Private | -- | 4,439 | -- | 338 | -- | 3,487 | -- | 1,915 | -- | 2,219 | -- | 144 |
| Medicaid/CHIP | -- | 3,199 | -- | 430 | -- | 2,422 | -- | 1,414 | -- | 1,359 | -- | 166 |
| Other3 | -- | 399 | -- | 51 | -- | 305 | -- | 178 | -- | 161 | -- | 22 |
| No Coverage | -- | 191 | -- | 25 | -- | 132 | -- | 35 | -- | 57 | -- | * |
| OVERALL HEALTH4 | ||||||||||||
| Excellent | -- | 1,643 | -- | 127 | -- | 1,264 | -- | 580 | -- | 581 | -- | 41 |
| Very Good | -- | 3,070 | -- | 257 | -- | 2,355 | -- | 1,236 | -- | 1,433 | -- | 118 |
| Good | -- | 2,320 | -- | 266 | -- | 1,784 | -- | 1,139 | -- | 1,202 | -- | 119 |
| Fair/Poor | -- | 634 | -- | 133 | -- | 504 | -- | 331 | -- | 345 | -- | 26 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple types/locations for receiving mental health treatment; thus, these response categories are not mutually exclusive. 1 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 4 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||||
| Geographic/Socioeconomic/ Health Characteristic |
Mental Health Treatment (2021) |
Mental Health Treatment (2022) |
Inpatient (2021) |
Inpatient (2022) |
Outpatient (2021) |
Outpatient (2022) |
Prescription Medication (2021) |
Prescription Medication (2022) |
Telehealth Treatment1 (2021) |
Telehealth Treatment1 (2022) |
Prison, Jail, or Juvenile Detention Center (2021) |
Prison, Jail, or Juvenile Detention Center (2022) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 29.8 | -- | 3.0 | -- | 23.0 | -- | 12.8 | -- | 13.8 | -- | 1.2 |
| GEOGRAPHIC REGION | ||||||||||||
| Northeast | -- | 30.9 | -- | 3.2 | -- | 25.1 | -- | 11.0 | -- | 16.5 | -- | 1.1 |
| Midwest | -- | 31.6 | -- | 2.8 | -- | 24.2 | -- | 14.3 | -- | 13.8 | -- | 1.3 |
| South | -- | 28.8 | -- | 3.4 | -- | 21.5 | -- | 13.6 | -- | 12.1 | -- | 1.0 |
| West | -- | 29.2 | -- | 2.5 | -- | 22.9 | -- | 11.2 | -- | 15.0 | -- | 1.5 |
| COUNTY TYPE | ||||||||||||
| Large Metro | -- | 29.4 | -- | 2.8 | -- | 22.9 | -- | 11.9 | -- | 14.0 | -- | 1.1 |
| Small Metro | -- | 31.1 | -- | 3.4 | -- | 23.6 | -- | 14.1 | -- | 14.4 | -- | 1.3 |
| Nonmetro | -- | 28.6 | -- | 3.1 | -- | 21.6 | -- | 13.8 | -- | 11.5 | -- | 1.4 |
| Urbanized | -- | 31.1 | -- | 3.3 | -- | 23.9 | -- | 14.0 | -- | 13.8 | -- | 2.1 |
| Less Urbanized | -- | 28.4 | -- | 1.9 | -- | 20.9 | -- | 14.6 | -- | 10.2 | -- | 0.8 |
| Completely Rural | -- | * | -- | * | -- | * | -- | 9.1 | -- | 7.4 | -- | 0.8 |
| POVERTY LEVEL | ||||||||||||
| Less Than 100% | -- | 25.0 | -- | 4.1 | -- | 18.6 | -- | 9.8 | -- | 10.0 | -- | 1.5 |
| 100-199% | -- | 29.9 | -- | 3.4 | -- | 22.8 | -- | 12.7 | -- | 12.2 | -- | 1.0 |
| 200% or More | -- | 31.5 | -- | 2.5 | -- | 24.6 | -- | 13.9 | -- | 15.9 | -- | 1.1 |
| HEALTH INSURANCE2 | ||||||||||||
| Private | -- | 31.5 | -- | 2.4 | -- | 24.8 | -- | 13.6 | -- | 15.8 | -- | 1.0 |
| Medicaid/CHIP | -- | 30.0 | -- | 4.0 | -- | 22.7 | -- | 13.2 | -- | 12.7 | -- | 1.6 |
| Other3 | -- | 26.5 | -- | 3.4 | -- | 20.2 | -- | 11.8 | -- | 10.7 | -- | 1.5 |
| No Coverage | -- | 18.9 | -- | 2.5 | -- | 13.1 | -- | 3.5 | -- | 5.6 | -- | * |
| OVERALL HEALTH4 | ||||||||||||
| Excellent | -- | 20.4 | -- | 1.6 | -- | 15.7 | -- | 7.2 | -- | 7.2 | -- | 0.5 |
| Very Good | -- | 30.3 | -- | 2.5 | -- | 23.2 | -- | 12.2 | -- | 14.1 | -- | 1.2 |
| Good | -- | 37.0 | -- | 4.2 | -- | 28.5 | -- | 18.2 | -- | 19.2 | -- | 1.9 |
| Fair/Poor | -- | 50.5 | -- | 10.6 | -- | 40.0 | -- | 26.3 | -- | 27.5 | -- | 2.1 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple types/locations for receiving mental health treatment; thus, these response categories are not mutually exclusive. 1 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 4 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||||
| Demographic Characteristic | Aged 12-171 (2021) |
Aged 12-171 (2022) |
Had MDE2 (2021) |
Had MDE2 (2022) |
Had MDE with Severe Impairment2,3 (2021) |
Had MDE with Severe Impairment2,3 (2022) |
No MDE2 (2021) |
No MDE2 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 783 | -- | 369 | -- | 335 | -- | 376 |
| AGE GROUP | ||||||||
| 12-13 | -- | 281 | -- | 103 | -- | 88 | -- | 160 |
| 14-15 | -- | 278 | -- | 162 | -- | 152 | -- | 101 |
| 16-17 | -- | 224 | -- | 105 | -- | 94 | -- | 114 |
| GENDER | ||||||||
| Male | -- | 314 | -- | 96 | -- | 90 | -- | 207 |
| Female | -- | 469 | -- | 273 | -- | 244 | -- | 168 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | -- | 591 | -- | 276 | -- | 250 | -- | 290 |
| AIAN | -- | 13 | -- | * | -- | * | -- | 2 |
| Asian | -- | 31 | -- | * | -- | * | -- | 3 |
| Black or African American | -- | 168 | -- | 41 | -- | 39 | -- | 119 |
| NHOPI | -- | * | -- | * | -- | * | -- | * |
| White | -- | 350 | -- | 189 | -- | 171 | -- | 148 |
| Two or More Races | -- | 26 | -- | 9 | -- | 8 | -- | 17 |
| Hispanic or Latino | -- | 192 | -- | 93 | -- | 85 | -- | 86 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. 1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data. 2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 3 Respondents with unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Aged 12-171 (2021) |
Aged 12-171 (2022) |
Had MDE2 (2021) |
Had MDE2 (2022) |
Had MDE with Severe Impairment2,3 (2021) |
Had MDE with Severe Impairment2,3 (2022) |
No MDE2 (2021) |
No MDE2 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 3.0 | -- | 7.7 | -- | 9.3 | -- | 1.9 |
| AGE GROUP | ||||||||
| 12-13 | -- | 3.3 | -- | 10.0 | -- | 12.3 | -- | 2.3 |
| 14-15 | -- | 3.1 | -- | 8.6 | -- | 10.7 | -- | 1.5 |
| 16-17 | -- | 2.7 | -- | 5.5 | -- | 6.5 | -- | 1.9 |
| GENDER | ||||||||
| Male | -- | 2.4 | -- | 6.6 | -- | 9.1 | -- | 1.8 |
| Female | -- | 3.7 | -- | 8.1 | -- | 9.4 | -- | 1.9 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | -- | 3.1 | -- | 7.7 | -- | 9.4 | -- | 2.0 |
| AIAN | -- | 5.8 | -- | * | -- | * | -- | 1.0 |
| Asian | -- | 1.9 | -- | * | -- | * | -- | 0.2 |
| Black or African American | -- | 4.8 | -- | 7.3 | -- | 9.7 | -- | 4.2 |
| NHOPI | -- | * | -- | * | -- | * | -- | * |
| White | -- | 2.7 | -- | 7.2 | -- | 8.7 | -- | 1.5 |
| Two or More Races | -- | 3.2 | -- | 5.6 | -- | 7.8 | -- | 2.6 |
| Hispanic or Latino | -- | 2.9 | -- | 7.5 | -- | 9.2 | -- | 1.7 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. 1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data. 2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 3 Respondents with unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic/Health Characteristic | Aged 12-171 (2021) |
Aged 12-171 (2022) |
Had MDE2 (2021) |
Had MDE2 (2022) |
Had MDE with Severe Impairment2,3 (2021) |
Had MDE with Severe Impairment2,3 (2022) |
No MDE2 (2021) |
No MDE2 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 783 | -- | 369 | -- | 335 | -- | 376 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | -- | 130 | -- | 65 | -- | 50 | -- | 60 |
| Midwest | -- | 151 | -- | 68 | -- | 67 | -- | 78 |
| South | -- | 348 | -- | 145 | -- | 134 | -- | 187 |
| West | -- | 153 | -- | 90 | -- | 83 | -- | 50 |
| COUNTY TYPE | ||||||||
| Large Metro | -- | 422 | -- | 206 | -- | 192 | -- | 199 |
| Small Metro | -- | 269 | -- | 117 | -- | 100 | -- | 135 |
| Nonmetro | -- | 92 | -- | 46 | -- | * | -- | 41 |
| POVERTY LEVEL | ||||||||
| Less Than 100% | -- | 218 | -- | 85 | -- | 77 | -- | 131 |
| 100-199% | -- | 196 | -- | 98 | -- | 86 | -- | 84 |
| 200% or More | -- | 369 | -- | 187 | -- | 171 | -- | 161 |
| HEALTH INSURANCE4 | ||||||||
| Private | -- | 338 | -- | 175 | -- | 163 | -- | 144 |
| Medicaid/CHIP | -- | 430 | -- | 205 | -- | 187 | -- | 211 |
| Other5 | -- | 51 | -- | 20 | -- | * | -- | 27 |
| No Coverage | -- | 25 | -- | * | -- | * | -- | 15 |
| OVERALL HEALTH6 | ||||||||
| Excellent | -- | 127 | -- | 39 | -- | 27 | -- | 85 |
| Very Good | -- | 257 | -- | 81 | -- | 76 | -- | 159 |
| Good | -- | 266 | -- | 144 | -- | 138 | -- | 106 |
| Fair/Poor | -- | 133 | -- | 106 | -- | 93 | -- | 25 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. 1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data. 2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 3 Respondents with unknown impairment data were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 6 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic/Health Characteristic | Aged 12-171 (2021) |
Aged 12-171 (2022) |
Had MDE2 (2021) |
Had MDE2 (2022) |
Had MDE with Severe Impairment2,3 (2021) |
Had MDE with Severe Impairment2,3 (2022) |
No MDE2 (2021) |
No MDE2 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 3.0 | -- | 7.7 | -- | 9.3 | -- | 1.9 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | -- | 3.2 | -- | 9.2 | -- | 9.8 | -- | 1.9 |
| Midwest | -- | 2.8 | -- | 7.2 | -- | 9.2 | -- | 1.8 |
| South | -- | 3.4 | -- | 7.7 | -- | 9.4 | -- | 2.4 |
| West | -- | 2.5 | -- | 7.1 | -- | 9.0 | -- | 1.1 |
| COUNTY TYPE | ||||||||
| Large Metro | -- | 2.8 | -- | 7.4 | -- | 9.2 | -- | 1.7 |
| Small Metro | -- | 3.4 | -- | 7.7 | -- | 8.9 | -- | 2.2 |
| Nonmetro | -- | 3.1 | -- | 8.7 | -- | * | -- | 1.8 |
| POVERTY LEVEL | ||||||||
| Less Than 100% | -- | 4.1 | -- | 10.2 | -- | 12.6 | -- | 3.1 |
| 100-199% | -- | 3.4 | -- | 8.5 | -- | 9.5 | -- | 1.9 |
| 200% or More | -- | 2.5 | -- | 6.6 | -- | 8.2 | -- | 1.4 |
| HEALTH INSURANCE4 | ||||||||
| Private | -- | 2.4 | -- | 6.5 | -- | 8.3 | -- | 1.3 |
| Medicaid/CHIP | -- | 4.0 | -- | 10.3 | -- | 12.0 | -- | 2.6 |
| Other5 | -- | 3.4 | -- | 6.8 | -- | * | -- | 2.3 |
| No Coverage | -- | 2.5 | -- | * | -- | * | -- | 1.9 |
| OVERALL HEALTH6 | ||||||||
| Excellent | -- | 1.6 | -- | 4.9 | -- | 4.8 | -- | 1.2 |
| Very Good | -- | 2.5 | -- | 4.5 | -- | 5.8 | -- | 2.0 |
| Good | -- | 4.2 | -- | 8.3 | -- | 10.5 | -- | 2.5 |
| Fair/Poor | -- | 10.6 | -- | 21.1 | -- | 22.8 | -- | 3.6 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. 1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data. 2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 3 Respondents with unknown impairment data were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 6 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Aged 12-171 (2021) |
Aged 12-171 (2022) |
Had MDE2 (2021) |
Had MDE2 (2022) |
Had MDE with Severe Impairment2,3 (2021) |
Had MDE with Severe Impairment2,3 (2022) |
No MDE2 (2021) |
No MDE2 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 5,907 | -- | 2,318 | -- | 1,927 | -- | 3,341 |
| AGE GROUP | ||||||||
| 12-13 | -- | 1,941 | -- | 520 | -- | 418 | -- | 1,300 |
| 14-15 | -- | 2,128 | -- | 932 | -- | 762 | -- | 1,121 |
| 16-17 | -- | 1,838 | -- | 865 | -- | 747 | -- | 920 |
| GENDER | ||||||||
| Male | -- | 2,250 | -- | 548 | -- | 453 | -- | 1,633 |
| Female | -- | 3,658 | -- | 1,770 | -- | 1,474 | -- | 1,709 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | -- | 4,427 | -- | 1,742 | -- | 1,448 | -- | 2,503 |
| AIAN | -- | 51 | -- | * | -- | * | -- | * |
| Asian | -- | 268 | -- | * | -- | * | -- | 144 |
| Black or African American | -- | 614 | -- | 180 | -- | 158 | -- | 398 |
| NHOPI | -- | * | -- | * | -- | * | -- | * |
| White | -- | 3,268 | -- | 1,379 | -- | 1,143 | -- | 1,773 |
| Two or More Races | -- | 216 | -- | * | -- | * | -- | 145 |
| Hispanic or Latino | -- | 1,481 | -- | 576 | -- | 479 | -- | 839 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. 1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data. 2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 3 Respondents with unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Aged 12-171 (2021) |
Aged 12-171 (2022) |
Had MDE2 (2021) |
Had MDE2 (2022) |
Had MDE with Severe Impairment2,3 (2021) |
Had MDE with Severe Impairment2,3 (2022) |
No MDE2 (2021) |
No MDE2 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 23.0 | -- | 48.1 | -- | 53.6 | -- | 16.8 |
| AGE GROUP | ||||||||
| 12-13 | -- | 23.0 | -- | 50.5 | -- | 58.2 | -- | 18.9 |
| 14-15 | -- | 23.5 | -- | 49.5 | -- | 53.7 | -- | 16.2 |
| 16-17 | -- | 22.3 | -- | 45.3 | -- | 51.2 | -- | 15.1 |
| GENDER | ||||||||
| Male | -- | 17.1 | -- | 37.7 | -- | 45.4 | -- | 14.6 |
| Female | -- | 29.1 | -- | 52.5 | -- | 56.7 | -- | 19.7 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | -- | 23.2 | -- | 48.5 | -- | 54.2 | -- | 16.9 |
| AIAN | -- | 23.0 | -- | * | -- | * | -- | * |
| Asian | -- | 16.7 | -- | * | -- | * | -- | 10.9 |
| Black or African American | -- | 17.5 | -- | 31.9 | -- | 39.2 | -- | 14.1 |
| NHOPI | -- | * | -- | * | -- | * | -- | * |
| White | -- | 25.4 | -- | 52.9 | -- | 58.0 | -- | 18.1 |
| Two or More Races | -- | 25.9 | -- | * | -- | * | -- | 22.4 |
| Hispanic or Latino | -- | 22.3 | -- | 46.7 | -- | 51.8 | -- | 16.5 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. 1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data. 2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 3 Respondents with unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic/Health Characteristic | Aged 12-171 (2021) |
Aged 12-171 (2022) |
Had MDE2 (2021) |
Had MDE2 (2022) |
Had MDE with Severe Impairment2,3 (2021) |
Had MDE with Severe Impairment2,3 (2022) |
No MDE2 (2021) |
No MDE2 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 5,907 | -- | 2,318 | -- | 1,927 | -- | 3,341 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | -- | 1,020 | -- | 365 | -- | 284 | -- | 617 |
| Midwest | -- | 1,305 | -- | 463 | -- | 387 | -- | 790 |
| South | -- | 2,173 | -- | 867 | -- | 720 | -- | 1,202 |
| West | -- | 1,409 | -- | 623 | -- | 536 | -- | 732 |
| COUNTY TYPE | ||||||||
| Large Metro | -- | 3,395 | -- | 1,302 | -- | 1,109 | -- | 1,950 |
| Small Metro | -- | 1,880 | -- | 759 | -- | 619 | -- | 1,039 |
| Nonmetro | -- | 633 | -- | 257 | -- | 199 | -- | 352 |
| POVERTY LEVEL | ||||||||
| Less Than 100% | -- | 980 | -- | 362 | -- | 295 | -- | 575 |
| 100-199% | -- | 1,320 | -- | 511 | -- | 452 | -- | 726 |
| 200% or More | -- | 3,607 | -- | 1,444 | -- | 1,180 | -- | 2,040 |
| HEALTH INSURANCE4 | ||||||||
| Private | -- | 3,487 | -- | 1,367 | -- | 1,120 | -- | 1,986 |
| Medicaid/CHIP | -- | 2,422 | -- | 927 | -- | 789 | -- | 1,385 |
| Other5 | -- | 305 | -- | * | -- | * | -- | 173 |
| No Coverage | -- | 132 | -- | * | -- | * | -- | 60 |
| OVERALL HEALTH6 | ||||||||
| Excellent | -- | 1,264 | -- | 298 | -- | 222 | -- | 922 |
| Very Good | -- | 2,355 | -- | 828 | -- | 685 | -- | 1,429 |
| Good | -- | 1,784 | -- | 859 | -- | 732 | -- | 827 |
| Fair/Poor | -- | 504 | -- | 333 | -- | 288 | -- | 163 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. 1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data. 2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 3 Respondents with unknown impairment data were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 6 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic/Health Characteristic | Aged 12-171 (2021) |
Aged 12-171 (2022) |
Had MDE2 (2021) |
Had MDE2 (2022) |
Had MDE with Severe Impairment2,3 (2021) |
Had MDE with Severe Impairment2,3 (2022) |
No MDE2 (2021) |
No MDE2 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 23.0 | -- | 48.1 | -- | 53.6 | -- | 16.8 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | -- | 25.1 | -- | 51.2 | -- | 55.6 | -- | 19.4 |
| Midwest | -- | 24.2 | -- | 48.5 | -- | 52.7 | -- | 18.6 |
| South | -- | 21.5 | -- | 45.9 | -- | 50.4 | -- | 15.3 |
| West | -- | 22.9 | -- | 49.2 | -- | 58.0 | -- | 15.9 |
| COUNTY TYPE | ||||||||
| Large Metro | -- | 22.9 | -- | 47.0 | -- | 53.0 | -- | 17.0 |
| Small Metro | -- | 23.6 | -- | 49.8 | -- | 54.8 | -- | 17.0 |
| Nonmetro | -- | 21.6 | -- | 48.6 | -- | 53.0 | -- | 15.4 |
| POVERTY LEVEL | ||||||||
| Less Than 100% | -- | 18.6 | -- | 43.5 | -- | 47.9 | -- | 13.7 |
| 100-199% | -- | 22.8 | -- | 44.5 | -- | 50.1 | -- | 16.5 |
| 200% or More | -- | 24.6 | -- | 50.8 | -- | 56.8 | -- | 18.1 |
| HEALTH INSURANCE4 | ||||||||
| Private | -- | 24.8 | -- | 50.6 | -- | 57.3 | -- | 18.2 |
| Medicaid/CHIP | -- | 22.7 | -- | 46.6 | -- | 50.8 | -- | 16.8 |
| Other5 | -- | 20.2 | -- | * | -- | * | -- | 15.1 |
| No Coverage | -- | 13.1 | -- | * | -- | * | -- | 7.7 |
| OVERALL HEALTH6 | ||||||||
| Excellent | -- | 15.7 | -- | 37.5 | -- | 39.4 | -- | 13.1 |
| Very Good | -- | 23.2 | -- | 46.2 | -- | 52.3 | -- | 17.9 |
| Good | -- | 28.5 | -- | 49.5 | -- | 55.8 | -- | 19.9 |
| Fair/Poor | -- | 40.0 | -- | 66.4 | -- | 70.3 | -- | 23.4 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. 1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data. 2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 3 Respondents with unknown impairment data were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 6 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Aged 12-171 (2021) |
Aged 12-171 (2022) |
Had MDE2 (2021) |
Had MDE2 (2022) |
Had MDE with Severe Impairment2,3 (2021) |
Had MDE with Severe Impairment2,3 (2022) |
No MDE2 (2021) |
No MDE2 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 3,287 | -- | 1,358 | -- | 1,159 | -- | 1,790 |
| AGE GROUP | ||||||||
| 12-13 | -- | 1,009 | -- | 273 | -- | 229 | -- | 673 |
| 14-15 | -- | 1,131 | -- | 514 | -- | 427 | -- | 575 |
| 16-17 | -- | 1,147 | -- | 571 | -- | 504 | -- | 541 |
| GENDER | ||||||||
| Male | -- | 1,468 | -- | 368 | -- | 292 | -- | 1,046 |
| Female | -- | 1,819 | -- | 989 | -- | 867 | -- | 743 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | -- | 2,602 | -- | 1,056 | -- | 876 | -- | 1,431 |
| AIAN | -- | 30 | -- | * | -- | * | -- | * |
| Asian | -- | 69 | -- | * | -- | * | -- | 30 |
| Black or African American | -- | 304 | -- | 80 | -- | 53 | -- | 205 |
| NHOPI | -- | * | -- | * | -- | * | -- | * |
| White | -- | 2,086 | -- | 890 | -- | 742 | -- | 1,104 |
| Two or More Races | -- | 112 | -- | * | -- | * | -- | 72 |
| Hispanic or Latino | -- | 685 | -- | 302 | -- | 284 | -- | 359 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. 1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data. 2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 3 Respondents with unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Aged 12-171 (2021) |
Aged 12-171 (2022) |
Had MDE2 (2021) |
Had MDE2 (2022) |
Had MDE with Severe Impairment2,3 (2021) |
Had MDE with Severe Impairment2,3 (2022) |
No MDE2 (2021) |
No MDE2 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 12.8 | -- | 28.1 | -- | 32.2 | -- | 9.0 |
| AGE GROUP | ||||||||
| 12-13 | -- | 12.0 | -- | 26.4 | -- | 31.9 | -- | 9.8 |
| 14-15 | -- | 12.5 | -- | 27.3 | -- | 30.1 | -- | 8.3 |
| 16-17 | -- | 14.0 | -- | 29.9 | -- | 34.5 | -- | 8.9 |
| GENDER | ||||||||
| Male | -- | 11.2 | -- | 25.4 | -- | 29.3 | -- | 9.3 |
| Female | -- | 14.5 | -- | 29.3 | -- | 33.4 | -- | 8.6 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | -- | 13.6 | -- | 29.4 | -- | 32.8 | -- | 9.7 |
| AIAN | -- | 13.5 | -- | * | -- | * | -- | * |
| Asian | -- | 4.3 | -- | * | -- | * | -- | 2.3 |
| Black or African American | -- | 8.7 | -- | 14.1 | -- | 13.3 | -- | 7.3 |
| NHOPI | -- | * | -- | * | -- | * | -- | * |
| White | -- | 16.2 | -- | 34.1 | -- | 37.7 | -- | 11.3 |
| Two or More Races | -- | 13.5 | -- | * | -- | * | -- | 11.0 |
| Hispanic or Latino | -- | 10.3 | -- | 24.5 | -- | 30.6 | -- | 7.1 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. 1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data. 2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 3 Respondents with unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic/Health Characteristic | Aged 12-171 (2021) |
Aged 12-171 (2022) |
Had MDE2 (2021) |
Had MDE2 (2022) |
Had MDE with Severe Impairment2,3 (2021) |
Had MDE with Severe Impairment2,3 (2022) |
No MDE2 (2021) |
No MDE2 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 3,287 | -- | 1,358 | -- | 1,159 | -- | 1,790 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | -- | 447 | -- | 165 | -- | 129 | -- | 264 |
| Midwest | -- | 771 | -- | 274 | -- | 244 | -- | 466 |
| South | -- | 1,379 | -- | 546 | -- | 447 | -- | 756 |
| West | -- | 690 | -- | 372 | -- | 340 | -- | 303 |
| COUNTY TYPE | ||||||||
| Large Metro | -- | 1,760 | -- | 740 | -- | 636 | -- | 942 |
| Small Metro | -- | 1,123 | -- | 476 | -- | 412 | -- | 603 |
| Nonmetro | -- | 405 | -- | 142 | -- | 111 | -- | 244 |
| POVERTY LEVEL | ||||||||
| Less Than 100% | -- | 516 | -- | 211 | -- | 176 | -- | 271 |
| 100-199% | -- | 735 | -- | 311 | -- | 271 | -- | 387 |
| 200% or More | -- | 2,036 | -- | 836 | -- | 713 | -- | 1,131 |
| HEALTH INSURANCE4 | ||||||||
| Private | -- | 1,915 | -- | 819 | -- | 687 | -- | 1,032 |
| Medicaid/CHIP | -- | 1,414 | -- | 543 | -- | 474 | -- | 800 |
| Other5 | -- | 178 | -- | * | -- | * | -- | 94 |
| No Coverage | -- | 35 | -- | * | -- | * | -- | 22 |
| OVERALL HEALTH6 | ||||||||
| Excellent | -- | 580 | -- | 162 | -- | 129 | -- | 402 |
| Very Good | -- | 1,236 | -- | 408 | -- | 345 | -- | 772 |
| Good | -- | 1,139 | -- | 565 | -- | 493 | -- | 510 |
| Fair/Poor | -- | 331 | -- | 222 | -- | 192 | -- | 104 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. 1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data. 2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 3 Respondents with unknown impairment data were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 6 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic/Health Characteristic | Aged 12-171 (2021) |
Aged 12-171 (2022) |
Had MDE2 (2021) |
Had MDE2 (2022) |
Had MDE with Severe Impairment2,3 (2021) |
Had MDE with Severe Impairment2,3 (2022) |
No MDE2 (2021) |
No MDE2 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 12.8 | -- | 28.1 | -- | 32.2 | -- | 9.0 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | -- | 11.0 | -- | 23.2 | -- | 25.2 | -- | 8.3 |
| Midwest | -- | 14.3 | -- | 28.7 | -- | 33.2 | -- | 11.0 |
| South | -- | 13.6 | -- | 28.9 | -- | 31.3 | -- | 9.6 |
| West | -- | 11.2 | -- | 29.4 | -- | 36.8 | -- | 6.6 |
| COUNTY TYPE | ||||||||
| Large Metro | -- | 11.9 | -- | 26.7 | -- | 30.4 | -- | 8.2 |
| Small Metro | -- | 14.1 | -- | 31.3 | -- | 36.5 | -- | 9.9 |
| Nonmetro | -- | 13.8 | -- | 26.8 | -- | 29.5 | -- | 10.7 |
| POVERTY LEVEL | ||||||||
| Less Than 100% | -- | 9.8 | -- | 25.3 | -- | 28.5 | -- | 6.5 |
| 100-199% | -- | 12.7 | -- | 27.0 | -- | 30.1 | -- | 8.8 |
| 200% or More | -- | 13.9 | -- | 29.4 | -- | 34.3 | -- | 10.0 |
| HEALTH INSURANCE4 | ||||||||
| Private | -- | 13.6 | -- | 30.3 | -- | 35.1 | -- | 9.5 |
| Medicaid/CHIP | -- | 13.2 | -- | 27.3 | -- | 30.6 | -- | 9.7 |
| Other5 | -- | 11.8 | -- | * | -- | * | -- | 8.2 |
| No Coverage | -- | 3.5 | -- | * | -- | * | -- | 2.8 |
| OVERALL HEALTH6 | ||||||||
| Excellent | -- | 7.2 | -- | 20.4 | -- | 22.8 | -- | 5.7 |
| Very Good | -- | 12.2 | -- | 22.8 | -- | 26.4 | -- | 9.7 |
| Good | -- | 18.2 | -- | 32.5 | -- | 37.6 | -- | 12.3 |
| Fair/Poor | -- | 26.3 | -- | 44.3 | -- | 46.9 | -- | 15.0 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. 1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data. 2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 3 Respondents with unknown impairment data were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 6 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Aged 12-171 (2021) |
Aged 12-171 (2022) |
Had MDE2 (2021) |
Had MDE2 (2022) |
Had MDE with Severe Impairment2,3 (2021) |
Had MDE with Severe Impairment2,3 (2022) |
No MDE2 (2021) |
No MDE2 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 3,561 | -- | 1,661 | -- | 1,405 | -- | 1,761 |
| AGE GROUP | ||||||||
| 12-13 | -- | 913 | -- | 324 | -- | 269 | -- | 527 |
| 14-15 | -- | 1,264 | -- | 679 | -- | 572 | -- | 545 |
| 16-17 | -- | 1,384 | -- | 658 | -- | 564 | -- | 689 |
| GENDER | ||||||||
| Male | -- | 1,282 | -- | 440 | -- | 358 | -- | 805 |
| Female | -- | 2,279 | -- | 1,221 | -- | 1,047 | -- | 956 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | -- | 2,770 | -- | 1,273 | -- | 1,064 | -- | 1,380 |
| AIAN | -- | * | -- | * | -- | * | -- | * |
| Asian | -- | 114 | -- | * | -- | * | -- | 56 |
| Black or African American | -- | 295 | -- | 130 | -- | 114 | -- | 158 |
| NHOPI | -- | * | -- | * | -- | * | -- | * |
| White | -- | 2,186 | -- | 1,040 | -- | 859 | -- | 1,052 |
| Two or More Races | -- | 135 | -- | 38 | -- | * | -- | 87 |
| Hispanic or Latino | -- | 791 | -- | 387 | -- | 341 | -- | 381 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. 1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data. 2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 3 Respondents with unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Aged 12-171 (2021) |
Aged 12-171 (2022) |
Had MDE2 (2021) |
Had MDE2 (2022) |
Had MDE with Severe Impairment2,3 (2021) |
Had MDE with Severe Impairment2,3 (2022) |
No MDE2 (2021) |
No MDE2 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 13.8 | -- | 34.4 | -- | 39.1 | -- | 8.9 |
| AGE GROUP | ||||||||
| 12-13 | -- | 10.8 | -- | 31.4 | -- | 37.5 | -- | 7.7 |
| 14-15 | -- | 14.0 | -- | 36.1 | -- | 40.3 | -- | 7.9 |
| 16-17 | -- | 16.8 | -- | 34.4 | -- | 38.6 | -- | 11.3 |
| GENDER | ||||||||
| Male | -- | 9.7 | -- | 30.3 | -- | 35.9 | -- | 7.2 |
| Female | -- | 18.1 | -- | 36.2 | -- | 40.3 | -- | 11.0 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | -- | 14.5 | -- | 35.5 | -- | 39.8 | -- | 9.3 |
| AIAN | -- | * | -- | * | -- | * | -- | * |
| Asian | -- | 7.1 | -- | * | -- | * | -- | 4.3 |
| Black or African American | -- | 8.4 | -- | 23.0 | -- | 28.4 | -- | 5.6 |
| NHOPI | -- | * | -- | * | -- | * | -- | * |
| White | -- | 17.0 | -- | 39.9 | -- | 43.6 | -- | 10.8 |
| Two or More Races | -- | 16.2 | -- | 24.6 | -- | * | -- | 13.4 |
| Hispanic or Latino | -- | 11.9 | -- | 31.4 | -- | 36.9 | -- | 7.5 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. 1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data. 2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 3 Respondents with unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic/Health Characteristic | Aged 12-171 (2021) |
Aged 12-171 (2022) |
Had MDE2 (2021) |
Had MDE2 (2022) |
Had MDE with Severe Impairment2,3 (2021) |
Had MDE with Severe Impairment2,3 (2022) |
No MDE2 (2021) |
No MDE2 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 3,561 | -- | 1,661 | -- | 1,405 | -- | 1,761 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | -- | 671 | -- | 295 | -- | 230 | -- | 349 |
| Midwest | -- | 744 | -- | 307 | -- | 268 | -- | 410 |
| South | -- | 1,224 | -- | 572 | -- | 482 | -- | 611 |
| West | -- | 922 | -- | 487 | -- | 425 | -- | 391 |
| COUNTY TYPE | ||||||||
| Large Metro | -- | 2,076 | -- | 963 | -- | 842 | -- | 1,047 |
| Small Metro | -- | 1,150 | -- | 546 | -- | 444 | -- | 543 |
| Nonmetro | -- | 336 | -- | 151 | -- | 120 | -- | 171 |
| POVERTY LEVEL | ||||||||
| Less Than 100% | -- | 528 | -- | 247 | -- | 214 | -- | 261 |
| 100-199% | -- | 705 | -- | 309 | -- | 278 | -- | 356 |
| 200% or More | -- | 2,328 | -- | 1,104 | -- | 913 | -- | 1,143 |
| HEALTH INSURANCE4 | ||||||||
| Private | -- | 2,219 | -- | 1,041 | -- | 856 | -- | 1,102 |
| Medicaid/CHIP | -- | 1,359 | -- | 618 | -- | 545 | -- | 682 |
| Other5 | -- | 161 | -- | 77 | -- | * | -- | 77 |
| No Coverage | -- | 57 | -- | * | -- | * | -- | 28 |
| OVERALL HEALTH6 | ||||||||
| Excellent | -- | 581 | -- | 177 | -- | 135 | -- | 388 |
| Very Good | -- | 1,433 | -- | 607 | -- | 513 | -- | 769 |
| Good | -- | 1,202 | -- | 642 | -- | 560 | -- | 495 |
| Fair/Poor | -- | 345 | -- | 234 | -- | 197 | -- | 109 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. 1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data. 2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 3 Respondents with unknown impairment data were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 6 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic/Health Characteristic | Aged 12-171 (2021) |
Aged 12-171 (2022) |
Had MDE2 (2021) |
Had MDE2 (2022) |
Had MDE with Severe Impairment2,3 (2021) |
Had MDE with Severe Impairment2,3 (2022) |
No MDE2 (2021) |
No MDE2 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 13.8 | -- | 34.4 | -- | 39.1 | -- | 8.9 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | -- | 16.5 | -- | 41.4 | -- | 45.0 | -- | 11.0 |
| Midwest | -- | 13.8 | -- | 32.2 | -- | 36.5 | -- | 9.6 |
| South | -- | 12.1 | -- | 30.3 | -- | 33.7 | -- | 7.8 |
| West | -- | 15.0 | -- | 38.4 | -- | 46.1 | -- | 8.5 |
| COUNTY TYPE | ||||||||
| Large Metro | -- | 14.0 | -- | 34.8 | -- | 40.2 | -- | 9.1 |
| Small Metro | -- | 14.4 | -- | 35.8 | -- | 39.3 | -- | 8.9 |
| Nonmetro | -- | 11.5 | -- | 28.6 | -- | 31.9 | -- | 7.5 |
| POVERTY LEVEL | ||||||||
| Less Than 100% | -- | 10.0 | -- | 29.7 | -- | 34.8 | -- | 6.2 |
| 100-199% | -- | 12.2 | -- | 26.9 | -- | 30.8 | -- | 8.1 |
| 200% or More | -- | 15.9 | -- | 38.9 | -- | 43.9 | -- | 10.1 |
| HEALTH INSURANCE4 | ||||||||
| Private | -- | 15.8 | -- | 38.5 | -- | 43.8 | -- | 10.1 |
| Medicaid/CHIP | -- | 12.7 | -- | 31.1 | -- | 35.2 | -- | 8.3 |
| Other5 | -- | 10.7 | -- | 26.1 | -- | * | -- | 6.8 |
| No Coverage | -- | 5.6 | -- | * | -- | * | -- | 3.6 |
| OVERALL HEALTH6 | ||||||||
| Excellent | -- | 7.2 | -- | 22.3 | -- | 23.9 | -- | 5.5 |
| Very Good | -- | 14.1 | -- | 33.9 | -- | 39.2 | -- | 9.6 |
| Good | -- | 19.2 | -- | 37.0 | -- | 42.7 | -- | 11.9 |
| Fair/Poor | -- | 27.5 | -- | 46.7 | -- | 48.2 | -- | 15.6 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. 1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data. 2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 3 Respondents with unknown impairment data were excluded. 4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 5 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 6 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment in Past Year | |||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 2,205 | -- | 381 | -- | 1,824 | -- | 15,520 |
| AGE GROUP | ||||||||
| 12-13 | -- | 446 | -- | 66 | -- | 380 | -- | 5,290 |
| 14-15 | -- | 840 | -- | 162 | -- | 678 | -- | 5,348 |
| 16-17 | -- | 920 | -- | 153 | -- | 766 | -- | 4,882 |
| GENDER | ||||||||
| Male | -- | 683 | -- | 150 | -- | 533 | -- | 9,050 |
| Female | -- | 1,522 | -- | 230 | -- | 1,291 | -- | 6,470 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | -- | 1,673 | -- | 252 | -- | 1,419 | -- | 11,377 |
| AIAN | -- | 9 | -- | 1 | -- | 9 | -- | 136 |
| Asian | -- | 194 | -- | 4 | -- | 190 | -- | 1,057 |
| Black or African American | -- | 237 | -- | 20 | -- | 217 | -- | 2,384 |
| NHOPI | -- | * | -- | * | -- | * | -- | * |
| White | -- | 1,163 | -- | 220 | -- | 942 | -- | 7,259 |
| Two or More Races | -- | 69 | -- | 8 | -- | 61 | -- | 490 |
| Hispanic or Latino | -- | 533 | -- | 128 | -- | 404 | -- | 4,143 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment in Past Year | |||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 12.4 | -- | 2.1 | -- | 10.3 | -- | 87.6 |
| AGE GROUP | ||||||||
| 12-13 | -- | 7.8 | -- | 1.1 | -- | 6.6 | -- | 92.2 |
| 14-15 | -- | 13.6 | -- | 2.6 | -- | 10.9 | -- | 86.4 |
| 16-17 | -- | 15.9 | -- | 2.6 | -- | 13.2 | -- | 84.1 |
| GENDER | ||||||||
| Male | -- | 7.0 | -- | 1.5 | -- | 5.5 | -- | 93.0 |
| Female | -- | 19.0 | -- | 2.8 | -- | 16.1 | -- | 81.0 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | -- | 12.8 | -- | 1.9 | -- | 10.9 | -- | 87.2 |
| AIAN | -- | 6.3 | -- | 0.4 | -- | 5.9 | -- | 93.7 |
| Asian | -- | 15.5 | -- | 0.3 | -- | 15.2 | -- | 84.5 |
| Black or African American | -- | 9.0 | -- | 0.7 | -- | 8.3 | -- | 91.0 |
| NHOPI | -- | * | -- | * | -- | * | -- | * |
| White | -- | 13.8 | -- | 2.6 | -- | 11.2 | -- | 86.2 |
| Two or More Races | -- | 12.3 | -- | 1.3 | -- | 11.0 | -- | 87.7 |
| Hispanic or Latino | -- | 11.4 | -- | 2.7 | -- | 8.6 | -- | 88.6 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic/Health Characteristic | Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment in Past Year | |||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 2,205 | -- | 381 | -- | 1,824 | -- | 15,520 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | -- | 324 | -- | 39 | -- | 284 | -- | 2,455 |
| Midwest | -- | 434 | -- | 69 | -- | 365 | -- | 3,198 |
| South | -- | 849 | -- | 151 | -- | 698 | -- | 6,220 |
| West | -- | 599 | -- | 122 | -- | 476 | -- | 3,647 |
| COUNTY TYPE | ||||||||
| Large Metro | -- | 1,333 | -- | 235 | -- | 1,098 | -- | 8,944 |
| Small Metro | -- | 627 | -- | 119 | -- | 507 | -- | 4,770 |
| Nonmetro | -- | 246 | -- | 26 | -- | 218 | -- | 1,806 |
| POVERTY LEVEL | ||||||||
| Less Than 100% | -- | 296 | -- | 64 | -- | 231 | -- | 3,578 |
| 100-199% | -- | 502 | -- | 85 | -- | 416 | -- | 3,452 |
| 200% or More | -- | 1,408 | -- | 231 | -- | 1,177 | -- | 8,490 |
| HEALTH INSURANCE1 | ||||||||
| Private | -- | 1,391 | -- | 223 | -- | 1,168 | -- | 8,099 |
| Medicaid/CHIP | -- | 706 | -- | 141 | -- | 564 | -- | 6,615 |
| Other2 | -- | 133 | -- | 36 | -- | 96 | -- | 960 |
| No Coverage | -- | 77 | -- | 17 | -- | 60 | -- | 720 |
| OVERALL HEALTH3 | ||||||||
| Excellent | -- | 548 | -- | 97 | -- | 451 | -- | 5,815 |
| Very Good | -- | 938 | -- | 159 | -- | 779 | -- | 5,997 |
| Good | -- | 595 | -- | 99 | -- | 496 | -- | 3,237 |
| Fair/Poor | -- | 124 | -- | 25 | -- | 99 | -- | 470 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 3 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic/Health Characteristic | Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment in Past Year | |||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 12.4 | -- | 2.1 | -- | 10.3 | -- | 87.6 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | -- | 11.7 | -- | 1.4 | -- | 10.2 | -- | 88.3 |
| Midwest | -- | 11.9 | -- | 1.9 | -- | 10.0 | -- | 88.1 |
| South | -- | 12.0 | -- | 2.1 | -- | 9.9 | -- | 88.0 |
| West | -- | 14.1 | -- | 2.8 | -- | 11.2 | -- | 85.9 |
| COUNTY TYPE | ||||||||
| Large Metro | -- | 13.0 | -- | 2.3 | -- | 10.7 | -- | 87.0 |
| Small Metro | -- | 11.6 | -- | 2.2 | -- | 9.4 | -- | 88.4 |
| Nonmetro | -- | 12.0 | -- | 1.3 | -- | 10.6 | -- | 88.0 |
| POVERTY LEVEL | ||||||||
| Less Than 100% | -- | 7.6 | -- | 1.6 | -- | 5.9 | -- | 92.4 |
| 100-199% | -- | 12.7 | -- | 2.1 | -- | 10.5 | -- | 87.3 |
| 200% or More | -- | 14.2 | -- | 2.3 | -- | 11.9 | -- | 85.8 |
| HEALTH INSURANCE1 | ||||||||
| Private | -- | 14.7 | -- | 2.3 | -- | 12.3 | -- | 85.3 |
| Medicaid/CHIP | -- | 9.6 | -- | 1.9 | -- | 7.7 | -- | 90.4 |
| Other2 | -- | 12.1 | -- | 3.3 | -- | 8.8 | -- | 87.9 |
| No Coverage | -- | 9.7 | -- | 2.1 | -- | 7.5 | -- | 90.3 |
| OVERALL HEALTH3 | ||||||||
| Excellent | -- | 8.6 | -- | 1.5 | -- | 7.1 | -- | 91.4 |
| Very Good | -- | 13.5 | -- | 2.3 | -- | 11.2 | -- | 86.5 |
| Good | -- | 15.5 | -- | 2.6 | -- | 12.9 | -- | 84.5 |
| Fair/Poor | -- | 20.9 | -- | 4.1 | -- | 16.6 | -- | 79.1 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 3 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Among People Aged 12 to 17 with Past Year Major Depressive Episode Who Did Not Receive Mental Health Treatment in Past Year |
|||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 987 | -- | 181 | -- | 805 | -- | 1,057 |
| AGE GROUP | ||||||||
| 12-13 | -- | 170 | -- | 17 | -- | 153 | -- | 244 |
| 14-15 | -- | 397 | -- | 77 | -- | 320 | -- | 386 |
| 16-17 | -- | 420 | -- | 87 | -- | 332 | -- | 426 |
| GENDER | ||||||||
| Male | -- | 270 | -- | * | -- | 196 | -- | 434 |
| Female | -- | 717 | -- | 107 | -- | 609 | -- | 622 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | -- | 748 | -- | 115 | -- | 632 | -- | 723 |
| AIAN | -- | * | -- | * | -- | * | -- | * |
| Asian | -- | * | -- | * | -- | * | -- | * |
| Black or African American | -- | 126 | -- | * | -- | 120 | -- | 189 |
| NHOPI | -- | * | -- | * | -- | * | -- | * |
| White | -- | 499 | -- | 104 | -- | 395 | -- | 434 |
| Two or More Races | -- | * | -- | * | -- | * | -- | * |
| Hispanic or Latino | -- | 239 | -- | * | -- | 174 | -- | 334 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Among People Aged 12 to 17 with Past Year Major Depressive Episode Who Did Not Receive Mental Health Treatment in Past Year |
|||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 48.3 | -- | 8.7 | -- | 39.4 | -- | 51.7 |
| AGE GROUP | ||||||||
| 12-13 | -- | 41.0 | -- | 3.8 | -- | 37.0 | -- | 59.0 |
| 14-15 | -- | 50.7 | -- | 9.7 | -- | 40.9 | -- | 49.3 |
| 16-17 | -- | 49.6 | -- | 10.3 | -- | 39.3 | -- | 50.4 |
| GENDER | ||||||||
| Male | -- | 38.3 | -- | * | -- | 27.9 | -- | 61.7 |
| Female | -- | 53.5 | -- | 7.9 | -- | 45.5 | -- | 46.5 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | -- | 50.8 | -- | 7.7 | -- | 43.0 | -- | 49.2 |
| AIAN | -- | * | -- | * | -- | * | -- | * |
| Asian | -- | * | -- | * | -- | * | -- | * |
| Black or African American | -- | 40.0 | -- | * | -- | 38.2 | -- | 60.0 |
| NHOPI | -- | * | -- | * | -- | * | -- | * |
| White | -- | 53.5 | -- | 11.1 | -- | 42.3 | -- | 46.5 |
| Two or More Races | -- | * | -- | * | -- | * | -- | * |
| Hispanic or Latino | -- | 41.7 | -- | * | -- | 30.3 | -- | 58.3 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic/Health Characteristic | Among People Aged 12 to 17 with Past Year Major Depressive Episode Who Did Not Receive Mental Health Treatment in Past Year | |||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 987 | -- | 181 | -- | 805 | -- | 1,057 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | -- | 139 | -- | 20 | -- | 118 | -- | 157 |
| Midwest | -- | 191 | -- | 41 | -- | 150 | -- | 184 |
| South | -- | 372 | -- | 52 | -- | 320 | -- | 452 |
| West | -- | 286 | -- | * | -- | 218 | -- | 263 |
| COUNTY TYPE | ||||||||
| Large Metro | -- | 575 | -- | 108 | -- | 466 | -- | 633 |
| Small Metro | -- | 292 | -- | 63 | -- | 229 | -- | 307 |
| Nonmetro | -- | * | -- | * | -- | * | -- | * |
| POVERTY LEVEL | ||||||||
| Less Than 100% | -- | 152 | -- | * | -- | 115 | -- | 236 |
| 100-199% | -- | 234 | -- | 40 | -- | 194 | -- | 295 |
| 200% or More | -- | 602 | -- | 105 | -- | 497 | -- | 526 |
| HEALTH INSURANCE1 | ||||||||
| Private | -- | 560 | -- | 107 | -- | 452 | -- | 510 |
| Medicaid/CHIP | -- | 393 | -- | 73 | -- | 319 | -- | 481 |
| Other2 | -- | * | -- | * | -- | * | -- | * |
| No Coverage | -- | * | -- | * | -- | * | -- | * |
| OVERALL HEALTH3 | ||||||||
| Excellent | -- | 204 | -- | 43 | -- | 161 | -- | 233 |
| Very Good | -- | 410 | -- | 76 | -- | 333 | -- | 384 |
| Good | -- | 314 | -- | 47 | -- | 267 | -- | 380 |
| Fair/Poor | -- | * | -- | * | -- | * | -- | * |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 3 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic/Health Characteristic | Among People Aged 12 to 17 with Past Year Major Depressive Episode Who Did Not Receive Mental Health Treatment in Past Year | |||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 48.3 | -- | 8.7 | -- | 39.4 | -- | 51.7 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | -- | 46.8 | -- | 6.8 | -- | 39.8 | -- | 53.2 |
| Midwest | -- | 50.9 | -- | 10.4 | -- | 40.0 | -- | 49.1 |
| South | -- | 45.1 | -- | 6.1 | -- | 38.9 | -- | 54.9 |
| West | -- | 52.1 | -- | * | -- | 39.7 | -- | 47.9 |
| COUNTY TYPE | ||||||||
| Large Metro | -- | 47.6 | -- | 8.7 | -- | 38.6 | -- | 52.4 |
| Small Metro | -- | 48.8 | -- | 10.3 | -- | 38.3 | -- | 51.2 |
| Nonmetro | -- | * | -- | * | -- | * | -- | * |
| POVERTY LEVEL | ||||||||
| Less Than 100% | -- | 39.2 | -- | * | -- | 29.7 | -- | 60.8 |
| 100-199% | -- | 44.2 | -- | 7.4 | -- | 36.6 | -- | 55.8 |
| 200% or More | -- | 53.4 | -- | 9.2 | -- | 44.1 | -- | 46.6 |
| HEALTH INSURANCE1 | ||||||||
| Private | -- | 52.4 | -- | 10.0 | -- | 42.3 | -- | 47.6 |
| Medicaid/CHIP | -- | 45.0 | -- | 8.1 | -- | 36.6 | -- | 55.0 |
| Other2 | -- | * | -- | * | -- | * | -- | * |
| No Coverage | -- | * | -- | * | -- | * | -- | * |
| OVERALL HEALTH3 | ||||||||
| Excellent | -- | 46.7 | -- | 9.9 | -- | 36.8 | -- | 53.3 |
| Very Good | -- | 51.6 | -- | 9.5 | -- | 42.0 | -- | 48.4 |
| Good | -- | 45.2 | -- | 6.5 | -- | 38.5 | -- | 54.8 |
| Fair/Poor | -- | * | -- | * | -- | * | -- | * |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 3 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Among People Aged 12 to 17 with Past Year Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment in Past Year |
|||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 760 | -- | 147 | -- | 612 | -- | 560 |
| AGE GROUP | ||||||||
| 12-13 | -- | 135 | -- | 13 | -- | 122 | -- | 100 |
| 14-15 | -- | 289 | -- | * | -- | 225 | -- | 236 |
| 16-17 | -- | 336 | -- | 70 | -- | 265 | -- | 225 |
| GENDER | ||||||||
| Male | -- | 197 | -- | * | -- | 136 | -- | 210 |
| Female | -- | 562 | -- | 85 | -- | 477 | -- | 350 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | -- | 573 | -- | 95 | -- | 478 | -- | 371 |
| AIAN | -- | * | -- | * | -- | * | -- | * |
| Asian | -- | * | -- | * | -- | * | -- | * |
| Black or African American | -- | * | -- | * | -- | * | -- | * |
| NHOPI | -- | * | -- | * | -- | * | -- | * |
| White | -- | 392 | -- | 84 | -- | 308 | -- | 219 |
| Two or More Races | -- | * | -- | * | -- | * | -- | * |
| Hispanic or Latino | -- | 186 | -- | * | -- | 135 | -- | 190 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Among People Aged 12 to 17 with Past Year Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment in Past Year |
|||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 57.6 | -- | 10.8 | -- | 46.4 | -- | 42.4 |
| AGE GROUP | ||||||||
| 12-13 | -- | 57.4 | -- | 5.0 | -- | 51.9 | -- | 42.6 |
| 14-15 | -- | 55.1 | -- | * | -- | 42.9 | -- | 44.9 |
| 16-17 | -- | 59.9 | -- | 12.4 | -- | 47.3 | -- | 40.1 |
| GENDER | ||||||||
| Male | -- | 48.4 | -- | * | -- | 33.3 | -- | 51.6 |
| Female | -- | 61.6 | -- | 9.1 | -- | 52.3 | -- | 38.4 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | -- | 60.7 | -- | 9.9 | -- | 50.6 | -- | 39.3 |
| AIAN | -- | * | -- | * | -- | * | -- | * |
| Asian | -- | * | -- | * | -- | * | -- | * |
| Black or African American | -- | * | -- | * | -- | * | -- | * |
| NHOPI | -- | * | -- | * | -- | * | -- | * |
| White | -- | 64.2 | -- | 13.7 | -- | 50.4 | -- | 35.8 |
| Two or More Races | -- | * | -- | * | -- | * | -- | * |
| Hispanic or Latino | -- | 49.6 | -- | * | -- | 35.8 | -- | 50.4 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic/Health Characteristic | Among People Aged 12 to 17 with Past Year Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment in Past Year |
|||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 760 | -- | 147 | -- | 612 | -- | 560 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | -- | * | -- | * | -- | * | -- | * |
| Midwest | -- | * | -- | * | -- | * | -- | * |
| South | -- | 302 | -- | 49 | -- | 253 | -- | 264 |
| West | -- | * | -- | * | -- | 145 | -- | * |
| COUNTY TYPE | ||||||||
| Large Metro | -- | 445 | -- | 100 | -- | 344 | -- | 331 |
| Small Metro | -- | 224 | -- | 44 | -- | 180 | -- | 173 |
| Nonmetro | -- | * | -- | * | -- | * | -- | * |
| POVERTY LEVEL | ||||||||
| Less Than 100% | -- | * | -- | * | -- | * | -- | * |
| 100-199% | -- | 186 | -- | 27 | -- | 159 | -- | 179 |
| 200% or More | -- | 442 | -- | 85 | -- | 357 | -- | 261 |
| HEALTH INSURANCE1 | ||||||||
| Private | -- | 400 | -- | 87 | -- | 312 | -- | 248 |
| Medicaid/CHIP | -- | 333 | -- | * | -- | 273 | -- | 278 |
| Other2 | -- | * | -- | * | -- | * | -- | * |
| No Coverage | -- | * | -- | * | -- | * | -- | * |
| OVERALL HEALTH3 | ||||||||
| Excellent | -- | * | -- | * | -- | * | -- | * |
| Very Good | -- | 312 | -- | * | -- | 242 | -- | 198 |
| Good | -- | 230 | -- | 29 | -- | 201 | -- | 205 |
| Fair/Poor | -- | * | -- | * | -- | * | -- | * |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 3 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic/Health Characteristic | Among People Aged 12 to 17 with Past Year Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment in Past Year |
|||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 57.6 | -- | 10.8 | -- | 46.4 | -- | 42.4 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | -- | * | -- | * | -- | * | -- | * |
| Midwest | -- | * | -- | * | -- | * | -- | * |
| South | -- | 53.3 | -- | 8.4 | -- | 44.6 | -- | 46.7 |
| West | -- | * | -- | * | -- | 45.8 | -- | * |
| COUNTY TYPE | ||||||||
| Large Metro | -- | 57.3 | -- | 12.4 | -- | 44.4 | -- | 42.7 |
| Small Metro | -- | 56.5 | -- | 11.0 | -- | 45.4 | -- | 43.5 |
| Nonmetro | -- | * | -- | * | -- | * | -- | * |
| POVERTY LEVEL | ||||||||
| Less Than 100% | -- | * | -- | * | -- | * | -- | * |
| 100-199% | -- | 50.9 | -- | 7.1 | -- | 43.5 | -- | 49.1 |
| 200% or More | -- | 62.9 | -- | 12.0 | -- | 50.8 | -- | 37.1 |
| HEALTH INSURANCE1 | ||||||||
| Private | -- | 61.7 | -- | 13.3 | -- | 48.2 | -- | 38.3 |
| Medicaid/CHIP | -- | 54.5 | -- | * | -- | 44.6 | -- | 45.5 |
| Other2 | -- | * | -- | * | -- | * | -- | * |
| No Coverage | -- | * | -- | * | -- | * | -- | * |
| OVERALL HEALTH3 | ||||||||
| Excellent | -- | * | -- | * | -- | * | -- | * |
| Very Good | -- | 61.1 | -- | * | -- | 47.6 | -- | 38.9 |
| Good | -- | 52.9 | -- | 6.2 | -- | 46.3 | -- | 47.1 |
| Fair/Poor | -- | * | -- | * | -- | * | -- | * |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 3 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Reason Did Not Receive Mental Health Treatment | Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment and Sought or Thought Should Get Mental Health Treatment in Past Year |
|||||
|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
|
| Thought It Would Cost Too Much | -- | 626 | -- | * | -- | 511 |
| Did Not Have Health Insurance Coverage for Mental Health Treatment | -- | 169 | -- | * | -- | 138 |
| Health Insurance Would Not Pay Enough of Costs for Treatment | -- | 123 | -- | * | -- | 107 |
| Did Not Know How or Where to Get Treatment | -- | 1,020 | -- | * | -- | 817 |
| Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to |
-- | 504 | -- | * | -- | 361 |
| No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to |
-- | 154 | -- | * | -- | 71 |
| Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times That Worked for Them |
-- | 393 | -- | * | -- | 288 |
| Did Not Have Enough Time for Treatment | -- | 683 | -- | * | -- | 545 |
| Worried That Information Would Not Be Kept Private | -- | 1,088 | -- | * | -- | 921 |
| Worried about What People Would Think or Say if They Got Treatment | -- | 1,157 | -- | * | -- | 994 |
| Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children |
-- | 197 | -- | * | -- | 162 |
| Not Ready to Start Treatment | -- | 892 | -- | * | -- | 774 |
| Thought They Should Have Been Able to Handle Their Mental Health, Emotions, or Behavior on Their Own |
-- | 1,740 | -- | 256 | -- | 1,483 |
| Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment |
-- | 831 | -- | * | -- | 694 |
| Afraid of Being Committed to Hospital or Forced into Treatment against Their Will |
-- | 737 | -- | * | -- | 616 |
| Thought They Would Be Told They Needed to Take Medication | -- | 670 | -- | * | -- | 539 |
| Did Not Think Treatment Would Help Them | -- | 929 | -- | * | -- | 794 |
| Thought No One Would Care if They Got Better | -- | 823 | -- | * | -- | 680 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving treatment data were excluded. NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Reason Did Not Receive Mental Health Treatment | Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment and Sought or Thought Should Get Mental Health Treatment in Past Year |
|||||
|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
|
| Thought It Would Cost Too Much | -- | 28.9 | -- | * | -- | 28.5 |
| Did Not Have Health Insurance Coverage for Mental Health Treatment | -- | 8.2 | -- | * | -- | 8.0 |
| Health Insurance Would Not Pay Enough of Costs for Treatment | -- | 6.0 | -- | * | -- | 6.3 |
| Did Not Know How or Where to Get Treatment | -- | 46.6 | -- | * | -- | 45.1 |
| Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to |
-- | 23.7 | -- | * | -- | 20.4 |
| No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to |
-- | 7.1 | -- | * | -- | 4.0 |
| Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times That Worked for Them |
-- | 18.3 | -- | * | -- | 16.1 |
| Did Not Have Enough Time for Treatment | -- | 31.6 | -- | * | -- | 30.5 |
| Worried That Information Would Not Be Kept Private | -- | 49.8 | -- | * | -- | 50.9 |
| Worried about What People Would Think or Say if They Got Treatment | -- | 52.8 | -- | * | -- | 54.8 |
| Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children |
-- | 9.0 | -- | * | -- | 8.9 |
| Not Ready to Start Treatment | -- | 41.3 | -- | * | -- | 43.3 |
| Thought They Should Have Been Able to Handle Their Mental Health, Emotions, or Behavior on Their Own |
-- | 80.5 | -- | 69.3 | -- | 82.8 |
| Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment |
-- | 38.2 | -- | * | -- | 38.5 |
| Afraid of Being Committed to Hospital or Forced into Treatment against Their Will |
-- | 34.0 | -- | * | -- | 34.3 |
| Thought They Would Be Told They Needed to Take Medication | -- | 30.7 | -- | * | -- | 29.8 |
| Did Not Think Treatment Would Help Them | -- | 43.0 | -- | * | -- | 44.5 |
| Thought No One Would Care if They Got Better | -- | 38.4 | -- | * | -- | 38.3 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving treatment data were excluded. NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Reason Did Not Receive Mental Health Treatment | Among People Aged 12 to 17 with Major Depressive Episode Who Did Not Receive Mental Health Treatment and Sought or Thought Should Get Mental Health Treatment in Past Year |
|||||
|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
|
| Thought It Would Cost Too Much | -- | 324 | -- | * | -- | 252 |
| Did Not Have Health Insurance Coverage for Mental Health Treatment | -- | 125 | -- | * | -- | 96 |
| Health Insurance Would Not Pay Enough of Costs for Treatment | -- | 82 | -- | * | -- | 66 |
| Did Not Know How or Where to Get Treatment | -- | 546 | -- | * | -- | 419 |
| Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to |
-- | 292 | -- | * | -- | 206 |
| No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to |
-- | 114 | -- | * | -- | 50 |
| Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times That Worked for Them |
-- | 235 | -- | * | -- | 154 |
| Did Not Have Enough Time for Treatment | -- | 341 | -- | * | -- | 247 |
| Worried That Information Would Not Be Kept Private | -- | 569 | -- | * | -- | 464 |
| Worried about What People Would Think or Say if They Got Treatment | -- | 590 | -- | * | -- | 487 |
| Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children |
-- | 132 | -- | * | -- | 102 |
| Not Ready to Start Treatment | -- | 432 | -- | * | -- | 356 |
| Thought They Should Have Been Able to Handle Their Mental Health, Emotions, or Behavior on Their Own |
-- | 844 | -- | * | -- | 686 |
| Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment |
-- | 472 | -- | * | -- | 387 |
| Afraid of Being Committed to Hospital or Forced into Treatment against Their Will |
-- | 438 | -- | * | -- | 342 |
| Thought They Would Be Told They Needed to Take Medication | -- | 387 | -- | * | -- | 295 |
| Did Not Think Treatment Would Help Them | -- | 501 | -- | * | -- | 419 |
| Thought No One Would Care if They Got Better | -- | 519 | -- | * | -- | 421 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving treatment data were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Reason Did Not Receive Mental Health Treatment | Among People Aged 12 to 17 with Major Depressive Episode Who Did Not Receive Mental Health Treatment and Sought or Thought Should Get Mental Health Treatment in Past Year |
|||||
|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
|
| Thought It Would Cost Too Much | -- | 33.3 | -- | * | -- | 31.9 |
| Did Not Have Health Insurance Coverage for Mental Health Treatment | -- | 13.3 | -- | * | -- | 12.5 |
| Health Insurance Would Not Pay Enough of Costs for Treatment | -- | 8.8 | -- | * | -- | 8.7 |
| Did Not Know How or Where to Get Treatment | -- | 55.5 | -- | * | -- | 52.1 |
| Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to |
-- | 30.2 | -- | * | -- | 26.2 |
| No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to |
-- | 11.7 | -- | * | -- | 6.3 |
| Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times That Worked for Them |
-- | 24.2 | -- | * | -- | 19.4 |
| Did Not Have Enough Time for Treatment | -- | 34.8 | -- | * | -- | 30.9 |
| Worried That Information Would Not Be Kept Private | -- | 57.8 | -- | * | -- | 57.7 |
| Worried about What People Would Think or Say if They Got Treatment | -- | 59.8 | -- | * | -- | 60.4 |
| Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children |
-- | 13.3 | -- | * | -- | 12.7 |
| Not Ready to Start Treatment | -- | 44.5 | -- | * | -- | 45.2 |
| Thought They Should Have Been Able to Handle Their Mental Health, Emotions, or Behavior on Their Own |
-- | 86.9 | -- | * | -- | 86.6 |
| Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment |
-- | 48.2 | -- | * | -- | 48.5 |
| Afraid of Being Committed to Hospital or Forced into Treatment against Their Will |
-- | 45.0 | -- | * | -- | 43.2 |
| Thought They Would Be Told They Needed to Take Medication | -- | 39.4 | -- | * | -- | 36.9 |
| Did Not Think Treatment Would Help Them | -- | 51.5 | -- | * | -- | 52.9 |
| Thought No One Would Care if They Got Better | -- | 53.9 | -- | * | -- | 53.8 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving treatment data were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Reason Did Not Receive Mental Health Treatment | Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment and Sought or Thought Should Get Mental Health Treatment in Past Year |
|||||
|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
|
| Thought It Would Cost Too Much | -- | 266 | -- | * | -- | 199 |
| Did Not Have Health Insurance Coverage for Mental Health Treatment | -- | 100 | -- | * | -- | 71 |
| Health Insurance Would Not Pay Enough of Costs for Treatment | -- | 66 | -- | * | -- | 52 |
| Did Not Know How or Where to Get Treatment | -- | 460 | -- | * | -- | 356 |
| Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to |
-- | 237 | -- | * | -- | 158 |
| No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to |
-- | 95 | -- | * | -- | 35 |
| Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times That Worked for Them |
-- | 205 | -- | * | -- | 132 |
| Did Not Have Enough Time for Treatment | -- | 267 | -- | * | -- | 182 |
| Worried That Information Would Not Be Kept Private | -- | 453 | -- | * | -- | 365 |
| Worried about What People Would Think or Say if They Got Treatment | -- | 487 | -- | * | -- | 406 |
| Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children |
-- | 111 | -- | * | -- | 84 |
| Not Ready to Start Treatment | -- | 344 | -- | * | -- | 282 |
| Thought They Should Have Been Able to Handle Their Mental Health, Emotions, or Behavior on Their Own |
-- | 657 | -- | * | -- | 529 |
| Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment |
-- | 399 | -- | * | -- | 328 |
| Afraid of Being Committed to Hospital or Forced into Treatment against Their Will |
-- | 356 | -- | * | -- | 276 |
| Thought They Would Be Told They Needed to Take Medication | -- | 324 | -- | * | -- | 251 |
| Did Not Think Treatment Would Help Them | -- | 407 | -- | * | -- | 339 |
| Thought No One Would Care if They Got Better | -- | 438 | -- | * | -- | 357 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving treatment data were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Reason Did Not Receive Mental Health Treatment | Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment and Sought or Thought Should Get Mental Health Treatment in Past Year |
|||||
|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
|
| Thought It Would Cost Too Much | -- | 35.4 | -- | * | -- | 33.0 |
| Did Not Have Health Insurance Coverage for Mental Health Treatment | -- | 13.9 | -- | * | -- | 12.3 |
| Health Insurance Would Not Pay Enough of Costs for Treatment | -- | 9.2 | -- | * | -- | 8.8 |
| Did Not Know How or Where to Get Treatment | -- | 60.7 | -- | * | -- | 58.2 |
| Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to |
-- | 32.0 | -- | * | -- | 26.7 |
| No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to |
-- | 12.6 | -- | * | -- | 5.7 |
| Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times That Worked for Them |
-- | 27.3 | -- | * | -- | 21.7 |
| Did Not Have Enough Time for Treatment | -- | 35.2 | -- | * | -- | 29.8 |
| Worried That Information Would Not Be Kept Private | -- | 59.8 | -- | * | -- | 59.8 |
| Worried about What People Would Think or Say if They Got Treatment | -- | 64.1 | -- | * | -- | 66.3 |
| Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children |
-- | 14.6 | -- | * | -- | 13.8 |
| Not Ready to Start Treatment | -- | 45.9 | -- | * | -- | 47.0 |
| Thought They Should Have Been Able to Handle Their Mental Health, Emotions, or Behavior on Their Own |
-- | 88.3 | -- | * | -- | 88.3 |
| Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment |
-- | 52.7 | -- | * | -- | 53.8 |
| Afraid of Being Committed to Hospital or Forced into Treatment against Their Will |
-- | 47.2 | -- | * | -- | 45.7 |
| Thought They Would Be Told They Needed to Take Medication | -- | 42.6 | -- | * | -- | 41.1 |
| Did Not Think Treatment Would Help Them | -- | 54.2 | -- | * | -- | 56.2 |
| Thought No One Would Care if They Got Better | -- | 58.8 | -- | * | -- | 59.8 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving treatment data were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. NOTE: Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Demographic Characteristic | Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment1 (2021) |
Had MDE with Severe Impairment1 (2022) |
Received Treatment for Depression in Past Year among People with MDE2 (2021) |
Received Treatment for Depression in Past Year among People with MDE2 (2022) |
Received Treatment for Depression in Past Year among People with MDE with Severe Impairment1,2 (2021) |
Received Treatment for Depression in Past Year among People with MDE with Severe Impairment1,2 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | 5,186 | 4,823 | 3,773 | 3,595 | 2,046 | 2,285 | 1,631 | 1,902 |
| AGE GROUP | ||||||||
| 12-13 | 1,130 | 1,030 | 788 | 718 | 361 | 474 | 298 | 369 |
| 14-15 | 1,754 | 1,881 | 1,345 | 1,419 | 724 | 847 | 597 | 703 |
| 16-17 | 2,302a | 1,911 | 1,639 | 1,458 | 961 | 964 | 736 | 831 |
| GENDER | ||||||||
| Male | 1,545 | 1,452 | 1,048 | 996 | 584 | 594 | 420 | 482 |
| Female | 3,641 | 3,371 | 2,725 | 2,599 | 1,462 | 1,691 | 1,210 | 1,420 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 3,716 | 3,590 | 2,740 | 2,669 | 1,619 | 1,750 | 1,294 | 1,455 |
| AIAN | * | 29 | * | 20 | * | * | * | * |
| Asian | 204 | 230 | 151 | 169 | * | * | * | * |
| Black or African American | 479 | 566 | 367 | 402 | 196 | 192 | 149 | 158 |
| NHOPI | * | * | * | * | * | * | * | * |
| White | 2,703 | 2,605 | 1,977 | 1,970 | 1,248 | 1,405 | 1,020 | 1,169 |
| Two or More Races | 241a | 153 | 167a | 101 | * | * | * | * |
| Hispanic or Latino | 1,470a | 1,233 | 1,033 | 926 | 426 | 535 | 336 | 447 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents with unknown impairment data were excluded. 2 Respondents with unknown past year treatment for depression data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment1 (2021) |
Had MDE with Severe Impairment1 (2022) |
Received Treatment for Depression in Past Year among People with MDE2 (2021) |
Received Treatment for Depression in Past Year among People with MDE2 (2022) |
Received Treatment for Depression in Past Year among People with MDE with Severe Impairment1,2 (2021) |
Received Treatment for Depression in Past Year among People with MDE with Severe Impairment1,2 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | 20.8 | 19.5 | 15.2 | 14.6 | 40.0b | 47.8 | 43.7b | 53.4 |
| AGE GROUP | ||||||||
| 12-13 | 13.5 | 13.0 | 9.5 | 9.1 | 33.0b | 46.9 | 38.7a | 52.2 |
| 14-15 | 21.3 | 21.4 | 16.4 | 16.2 | 41.5 | 45.6 | 44.6 | 50.2 |
| 16-17 | 27.5a | 23.8 | 19.6 | 18.2 | 42.2a | 50.5 | 45.3b | 57.0 |
| GENDER | ||||||||
| Male | 12.0 | 11.5 | 8.2 | 7.9 | 38.6 | 41.3 | 41.0 | 49.0 |
| Female | 30.1 | 28.0 | 22.6 | 21.7 | 40.5b | 50.6 | 44.7b | 55.1 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 20.0 | 19.5 | 14.8 | 14.5 | 44.0 | 49.0 | 47.6a | 54.8 |
| AIAN | * | 14.1 | * | 9.7 | * | * | * | * |
| Asian | 15.0 | 14.9 | 11.1 | 11.0 | * | * | * | * |
| Black or African American | 14.1 | 16.7 | 10.8 | 11.9 | 41.2 | 34.5 | 40.8 | 40.0 |
| NHOPI | * | * | * | * | * | * | * | * |
| White | 21.4 | 21.0 | 15.7 | 15.9 | 46.5a | 54.1 | 51.7a | 59.5 |
| Two or More Races | 27.9a | 19.1 | 19.2a | 12.7 | * | * | * | * |
| Hispanic or Latino | 23.1 | 19.5 | 16.4 | 14.7 | 29.7b | 44.3 | 33.3b | 49.3 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents with unknown impairment data were excluded. 2 Respondents with unknown past year treatment for depression data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic/ Health Characteristic |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment1 (2021) |
Had MDE with Severe Impairment1 (2022) |
Received Treatment for Depression in Past Year among People with MDE2 (2021) |
Received Treatment for Depression in Past Year among People with MDE2 (2022) |
Received Treatment for Depression in Past Year among People with MDE with Severe Impairment1,2 (2021) |
Received Treatment for Depression in Past Year among People with MDE with Severe Impairment1,2 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | 5,186 | 4,823 | 3,773 | 3,595 | 2,046 | 2,285 | 1,631 | 1,902 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 811 | 713 | 537 | 510 | 311 | 380 | 228 | 279 |
| Midwest | 1,214b | 954 | 884 | 735 | 524 | 473 | 405 | 407 |
| South | 1,791 | 1,888 | 1,310 | 1,428 | 734 | 832 | 580 | 691 |
| West | 1,370 | 1,268 | 1,041 | 923 | 478 | 600 | 418 | 525 |
| COUNTY TYPE | ||||||||
| Large Metro | 2,654 | 2,771 | 1,938 | 2,091 | 1,078 | 1,302 | 847a | 1,107 |
| Small Metro | 1,707 | 1,524 | 1,261 | 1,129 | 661 | 756 | 560 | 614 |
| Nonmetro | 826b | 529 | 573b | 375 | 306 | 228 | 224 | 182 |
| POVERTY LEVEL | ||||||||
| Less Than 100% | 963 | 833 | 709 | 616 | 324 | 340 | 283 | 287 |
| 100-199% | 1,168 | 1,149 | 865 | 901 | 439 | 522 | 377 | 437 |
| 200% or More | 3,055 | 2,841 | 2,198 | 2,079 | 1,282 | 1,424 | 971 | 1,178 |
| HEALTH INSURANCE3 | ||||||||
| Private | 2,835 | 2,700 | 2,065 | 1,955 | 1,230 | 1,378 | 941a | 1,153 |
| Medicaid/CHIP | 2,053 | 1,989 | 1,495 | 1,552 | 770 | 915 | 648 | 764 |
| Other4 | 287 | 295 | 218 | 213 | * | * | * | * |
| No Coverage | 301b | 153 | 226a | 119 | * | * | * | * |
| OVERALL HEALTH5 | ||||||||
| Excellent | 1,030a | 795 | 653 | 565 | 342 | 312 | 268 | 225 |
| Very Good | 1,818 | 1,791 | 1,318 | 1,309 | 776 | 798 | 589 | 687 |
| Good | 1,751 | 1,736 | 1,309 | 1,312 | 645a | 867 | 531a | 726 |
| Fair/Poor | 588 | 501 | 492 | 409 | 282 | 308 | 243 | 265 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents with unknown impairment data were excluded. 2 Respondents with unknown past year treatment for depression data were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 5 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic/ Health Characteristic |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment1 (2021) |
Had MDE with Severe Impairment1 (2022) |
Received Treatment for Depression in Past Year among People with MDE2 (2021) |
Received Treatment for Depression in Past Year among People with MDE2 (2022) |
Received Treatment for Depression in Past Year among People with MDE with Severe Impairment1,2 (2021) |
Received Treatment for Depression in Past Year among People with MDE with Severe Impairment1,2 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | 20.8 | 19.5 | 15.2 | 14.6 | 40.0b | 47.8 | 43.7b | 53.4 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 20.7 | 18.3 | 13.7 | 13.1 | 39.2a | 53.5 | 43.4 | 54.9 |
| Midwest | 23.0b | 18.3 | 16.8 | 14.1 | 43.3 | 49.7 | 46.1 | 55.6 |
| South | 18.3 | 19.4 | 13.4 | 14.7 | 41.4 | 44.8 | 44.5 | 49.3 |
| West | 23.0 | 21.6 | 17.7 | 15.7 | 35.4a | 47.6 | 40.8b | 56.9 |
| COUNTY TYPE | ||||||||
| Large Metro | 19.8 | 19.4 | 14.5 | 14.7 | 41.2 | 47.6 | 44.3b | 53.6 |
| Small Metro | 22.0 | 20.0 | 16.4 | 14.8 | 39.2a | 49.8 | 44.8a | 54.6 |
| Nonmetro | 21.9 | 18.8 | 15.3 | 13.3 | 37.6 | 43.1 | 39.3 | 48.4 |
| POVERTY LEVEL | ||||||||
| Less Than 100% | 18.4 | 16.6 | 13.6 | 12.3 | 34.9 | 41.7 | 41.4 | 48.0 |
| 100-199% | 21.6 | 20.7 | 16.1 | 16.3 | 38.4 | 45.6 | 44.3 | 48.7 |
| 200% or More | 21.4 | 20.1 | 15.4 | 14.7 | 42.1b | 50.4 | 44.2b | 57.0 |
| HEALTH INSURANCE3 | ||||||||
| Private | 21.3 | 19.8 | 15.5 | 14.4 | 43.6a | 51.4 | 45.7b | 59.3 |
| Medicaid/CHIP | 19.9 | 19.5 | 14.6 | 15.2 | 38.5a | 46.6 | 44.4 | 49.9 |
| Other4 | 21.7 | 20.5 | 16.5 | 14.8 | * | * | * | * |
| No Coverage | 23.7 | 16.3 | 18.0 | 12.7 | * | * | * | * |
| OVERALL HEALTH5 | ||||||||
| Excellent | 12.6a | 10.2 | 8.0 | 7.2 | 33.3 | 39.2 | 41.1 | 39.9 |
| Very Good | 19.3 | 18.3 | 14.0 | 13.4 | 43.4 | 44.8 | 45.3 | 52.6 |
| Good | 28.7 | 29.4 | 21.4 | 22.3 | 37.6b | 50.8 | 41.2b | 56.4 |
| Fair/Poor | 46.4 | 41.8 | 39.5 | 34.5 | 48.2a | 61.9 | 49.5a | 65.0 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents with unknown impairment data were excluded. 2 Respondents with unknown past year treatment for depression data were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 5 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Type of Professional1 | Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment2 (2021) |
Had MDE with Severe Impairment2 (2022) |
|---|---|---|---|---|
| TOTAL | 1,922 | 2,130 | 1,553 | 1,764 |
| HEALTH PROFESSIONAL | 1,842 | 2,052 | 1,497 | 1,708 |
| General Practitioner or Family Doctor | 521a | 731 | 417b | 651 |
| Other Medical Doctor3 | 115 | 123 | 95 | 115 |
| Psychologist | 651 | 771 | 519 | 637 |
| Psychiatrist or Psychotherapist | 566 | 605 | 474 | 523 |
| Social Worker | 291 | 372 | 252 | 320 |
| Counselor | 1,068a | 1,334 | 904a | 1,161 |
| Other Mental Health Professional4 | 313 | 358 | 261 | 314 |
| Nurse, Occupational Therapist, or Other Health Professional | 250b | 423 | 226b | 387 |
| ALTERNATIVE SERVICE PROFESSIONAL | 129 | 186 | 107 | 159 |
| Religious or Spiritual Advisor | 72a | 137 | 55a | 110 |
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 59 | 56 | 54 | 53 |
| OTHER PROFESSIONAL5 | 2 | 19 | 2 | 17 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded from the estimates for each specific type of professional but were included in the Total row. 2 Respondents with unknown impairment data were excluded. 3 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 4 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 5 Respondents with unknown or invalid responses to the write-in question on other types of professionals seen for depression were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||
| Type of Professional1 | Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment2 (2021) |
Had MDE with Severe Impairment2 (2022) |
|---|---|---|---|---|
| TOTAL | 100.0 | 100.0 | 100.0 | 100.0 |
| HEALTH PROFESSIONAL | 99.0 | 98.6 | 98.8 | 99.0 |
| General Practitioner or Family Doctor | 28.0a | 35.1 | 27.5b | 37.7 |
| Other Medical Doctor3 | 6.2 | 5.9 | 6.3 | 6.7 |
| Psychologist | 35.0 | 37.0 | 34.3 | 36.9 |
| Psychiatrist or Psychotherapist | 30.4 | 29.1 | 31.3 | 30.3 |
| Social Worker | 15.6 | 17.9 | 16.7 | 18.6 |
| Counselor | 57.4a | 64.1 | 59.7a | 67.3 |
| Other Mental Health Professional4 | 16.8 | 17.2 | 17.3 | 18.2 |
| Nurse, Occupational Therapist, or Other Health Professional | 13.4b | 20.3 | 14.9a | 22.4 |
| ALTERNATIVE SERVICE PROFESSIONAL | 6.9 | 8.9 | 7.1 | 9.2 |
| Religious or Spiritual Advisor | 3.9 | 6.6 | 3.6 | 6.4 |
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 3.2 | 2.7 | 3.6 | 3.1 |
| OTHER PROFESSIONAL5 | 0.1 | 0.9 | 0.1 | 1.0 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded from the estimates for each specific type of professional but were included in the Total row. 2 Respondents with unknown impairment data were excluded. 3 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 4 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 5 Respondents with unknown or invalid responses to the write-in question on other types of professionals seen for depression were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||
| Demographic/Socioeconomic Characteristic | Saw or Talked to a Health Professional OR Used Prescription Medication (2021) |
Saw or Talked to a Health Professional OR Used Prescription Medication (2022) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2021) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2022) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2021) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2022) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2021) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | 1,989 | 2,234 | 930 | 1,064 | 120 | 136 | 911 | 980 |
| GENDER | ||||||||
| Male | 556 | 567 | 230 | 280 | 50 | 39 | 260 | 232 |
| Female | 1,433 | 1,667 | 700 | 784 | 71 | 97 | 650 | 748 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 1,580 | 1,724 | 715 | 795 | 89 | 121 | 757 | 786 |
| AIAN | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * |
| Black or African American | 179 | 186 | 114 | 133 | * | 6 | 43 | 45 |
| NHOPI | * | * | * | * | * | * | * | * |
| White | 1,226 | 1,387 | 520 | 597 | 62 | 109 | 624 | 663 |
| Two or More Races | * | * | * | * | 4 | * | 21 | * |
| Hispanic or Latino | 409 | 510 | 215 | 270 | 32 | 14 | 154 | 194 |
| POVERTY LEVEL | ||||||||
| Less Than 100% | 318 | 333 | 156 | 162 | 29 | 25 | 127 | 126 |
| 100-199% | 417 | 506 | 213 | 239 | 33 | 35 | 170 | 227 |
| 200% or More | 1,254 | 1,395 | 561 | 663 | 58 | 76 | 614 | 627 |
| HEALTH INSURANCE1 | ||||||||
| Private | 1,207 | 1,355 | 566 | 641 | 50 | 80 | 573 | 618 |
| Medicaid/CHIP | 752 | 892 | 329 | 438 | 78 | 64 | 333 | 355 |
| Other2 | * | * | * | * | * | * | 49 | * |
| No Coverage | * | * | * | * | 0 | * | * | * |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown past year treatment for depression data were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic/Socioeconomic Characteristic | Saw or Talked to a Health Professional OR Used Prescription Medication (2021) |
Saw or Talked to a Health Professional OR Used Prescription Medication (2022) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2021) |
Saw or Talked to a Health Professional BUT Did Not Use Prescription Medication (2022) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2021) |
Used Prescription Medication BUT Did Not See or Talk to a Health Professional (2022) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2021) |
Saw or Talked to a Health Professional AND Used Prescription Medication (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | 39.1b | 47.0 | 18.3a | 22.4 | 2.4 | 2.9 | 17.8 | 20.7 |
| GENDER | ||||||||
| Male | 37.4 | 39.6 | 15.4 | 19.5 | 3.3 | 2.7 | 17.3 | 16.3 |
| Female | 39.9b | 50.1 | 19.4 | 23.6 | 2.0 | 2.9 | 18.0a | 22.5 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 43.2 | 48.5 | 19.5 | 22.4 | 2.4 | 3.4 | 20.6 | 22.1 |
| AIAN | * | * | * | * | * | * | * | * |
| Asian | * | * | * | * | * | * | * | * |
| Black or African American | 38.8 | 33.6 | 24.7 | 24.1 | * | 1.2 | 9.2 | 7.9 |
| NHOPI | * | * | * | * | * | * | * | * |
| White | 45.8a | 53.6 | 19.4 | 23.1 | 2.3 | 4.2 | 23.3 | 25.6 |
| Two or More Races | * | * | * | * | 1.6 | * | 8.8 | * |
| Hispanic or Latino | 28.7b | 42.5 | 15.1a | 22.5 | 2.2 | 1.2 | 10.6a | 16.4 |
| POVERTY LEVEL | ||||||||
| Less Than 100% | 34.5 | 40.9 | 16.8 | 19.9 | 3.1 | 3.1 | 13.5 | 15.7 |
| 100-199% | 36.9 | 44.5 | 18.9 | 21.1 | 2.9 | 3.0 | 14.7 | 19.9 |
| 200% or More | 41.4b | 49.7 | 18.5a | 23.7 | 1.9 | 2.7 | 20.3 | 22.4 |
| HEALTH INSURANCE1 | ||||||||
| Private | 42.9a | 50.8 | 20.1 | 24.0 | 1.8 | 3.0 | 20.4 | 23.2 |
| Medicaid/CHIP | 37.8a | 45.5 | 16.5a | 22.5 | 3.9 | 3.3 | 16.5 | 18.3 |
| Other2 | * | * | * | * | * | * | 17.0 | * |
| No Coverage | * | * | * | * | 0.1 | * | * | * |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown past year treatment for depression data were excluded. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance | Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment1 (2021) |
Had MDE with Severe Impairment1 (2022) |
Had No MDE (2021) |
Had No MDE (2022) |
|---|---|---|---|---|---|---|
| ILLICIT DRUGS2 | 1,468 | 1,257 | 1,187 | 1,029 | 2,189 | 2,289 |
| Marijuana | 1,093 | 1,066 | 859 | 895 | 1,636 | 1,766 |
| Cocaine | 6 | 25 | 6 | 13 | 18 | 15 |
| Crack | 1 | * | 1 | * | 2 | * |
| Heroin | * | * | * | * | * | * |
| Hallucinogens | 147 | 142 | 121 | 122 | 220 | 195 |
| LSD | 108 | 84 | 86 | 71 | 155a | 72 |
| PCP | 5 | 0 | 5 | 0 | 14 | 14 |
| Ecstasy | 47 | 29 | 44 | 17 | 44 | 33 |
| Inhalants | 259a | 170 | 228a | 138 | 345 | 370 |
| Methamphetamine | 14 | 9 | 14 | 7 | 20 | 8 |
| Misuse of Prescription Psychotherapeutics | 415b | 249 | 372b | 193 | 431 | 371 |
| Pain Relievers | 241a | 143 | 219a | 111 | 267 | 253 |
| Stimulants | 145 | 97 | 124 | 75 | 146 | 119 |
| Tranquilizers or Sedatives | 134 | 72 | 131 | 67 | 100 | 61 |
| Tranquilizers | 116 | 57 | 113 | 51 | 90 | 55 |
| Sedatives | 31 | 21 | 31 | 21 | 11 | 7 |
| Benzodiazepines | 97 | 56 | 94 | 51 | 91 | 53 |
| Opioids2 | 241a | 143 | 219a | 111 | 267 | 253 |
| Central Nervous System Stimulants | 147 | 123 | 126 | 90 | 169 | 139 |
| Illicit Drugs Other Than Marijuana2,3 | 656b | 464 | 570b | 362 | 902 | 829 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING | -- | 1,256 | -- | 991 | -- | 2,445 |
| Tobacco Products | 523a | 377 | 447a | 304 | 917 | 810 |
| Cigarettes | 385 | 313 | 323 | 246 | 595 | 540 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 122a | 44 | 97a | 43 | 237a | 141 |
| Cigars | 198a | 106 | 180a | 96 | 359 | 296 |
| Pipe Tobacco4 | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 1,206 | -- | 957 | -- | 2,228 |
| ALCOHOL | 1,754b | 1,362 | 1,359a | 1,077 | 2,846 | 2,789 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL | -- | 145 | -- | 111 | -- | 265 |
| Illegally Made Fentanyl | -- | 7 | -- | 5 | -- | 14 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents with unknown impairment data were excluded. 2 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 3 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 4 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Substance | Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment1 (2021) |
Had MDE with Severe Impairment1 (2022) |
Had No MDE (2021) |
Had No MDE (2022) |
|---|---|---|---|---|---|---|
| ILLICIT DRUGS2 | 28.3 | 26.1 | 31.5 | 28.6 | 11.1 | 11.5 |
| Marijuana | 21.1 | 22.1 | 22.8 | 24.9 | 8.3 | 8.9 |
| Cocaine | 0.1 | 0.5 | 0.2 | 0.4 | 0.1 | 0.1 |
| Crack | 0.0 | * | 0.0 | * | 0.0 | * |
| Heroin | * | * | * | * | * | * |
| Hallucinogens | 2.8 | 3.0 | 3.2 | 3.4 | 1.1 | 1.0 |
| LSD | 2.1 | 1.8 | 2.3 | 2.0 | 0.8a | 0.4 |
| PCP | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 |
| Ecstasy | 0.9 | 0.6 | 1.2 | 0.5 | 0.2 | 0.2 |
| Inhalants | 5.0 | 3.5 | 6.1a | 3.8 | 1.7 | 1.9 |
| Methamphetamine | 0.3 | 0.2 | 0.4 | 0.2 | 0.1 | 0.0 |
| Misuse of Prescription Psychotherapeutics | 8.0a | 5.2 | 9.9b | 5.4 | 2.2 | 1.9 |
| Pain Relievers | 4.6 | 3.0 | 5.8a | 3.1 | 1.3 | 1.3 |
| Stimulants | 2.8 | 2.0 | 3.3 | 2.1 | 0.7 | 0.6 |
| Tranquilizers or Sedatives | 2.6 | 1.5 | 3.5 | 1.9 | 0.5 | 0.3 |
| Tranquilizers | 2.2 | 1.2 | 3.0 | 1.4 | 0.5 | 0.3 |
| Sedatives | 0.6 | 0.4 | 0.8 | 0.6 | 0.1 | 0.0 |
| Benzodiazepines | 1.9 | 1.2 | 2.5 | 1.4 | 0.5 | 0.3 |
| Opioids2 | 4.6 | 3.0 | 5.8a | 3.1 | 1.3 | 1.3 |
| Central Nervous System Stimulants | 2.8 | 2.6 | 3.3 | 2.5 | 0.9 | 0.7 |
| Illicit Drugs Other Than Marijuana2,3 | 12.6a | 9.6 | 15.1b | 10.1 | 4.6 | 4.2 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING | -- | 26.0 | -- | 27.6 | -- | 12.3 |
| Tobacco Products | 10.1 | 7.8 | 11.9a | 8.4 | 4.6 | 4.1 |
| Cigarettes | 7.4 | 6.5 | 8.6 | 6.8 | 3.0 | 2.7 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 2.4a | 0.9 | 2.6 | 1.2 | 1.2a | 0.7 |
| Cigars | 3.8a | 2.2 | 4.8a | 2.7 | 1.8 | 1.5 |
| Pipe Tobacco4 | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 25.0 | -- | 26.6 | -- | 11.2 |
| ALCOHOL | 33.8b | 28.2 | 36.0a | 30.0 | 14.4 | 14.0 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL | -- | 3.0 | -- | 3.1 | -- | 1.3 |
| Illegally Made Fentanyl | -- | 0.1 | -- | 0.1 | -- | 0.1 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents with unknown impairment data were excluded. 2 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 3 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 4 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Substance Use Disorder Status/Age Group | Total (2021) |
Total (2022) |
Male (2021) |
Male (2022) |
Female (2021) |
Female (2022) |
|---|---|---|---|---|---|---|
| SUBSTANCE USE DISORDER1 | 1,018 | 922 | 310 | 285 | 708 | 637 |
| 12-13 | * | * | * | * | * | * |
| 14-15 | 308 | 315 | 54 | 68 | 254 | 247 |
| 16-17 | 563 | 488 | * | 179 | 357 | 309 |
| Drug Use Disorder1 | 782 | 769 | 261 | 241 | 522 | 528 |
| 12-13 | * | * | * | * | * | * |
| 14-15 | 227 | 273 | * | * | * | * |
| 16-17 | 458 | 410 | * | 151 | 277 | 259 |
| Alcohol Use Disorder | 506a | 339 | * | * | 373a | 243 |
| 12-13 | * | * | * | * | * | * |
| 14-15 | * | * | * | * | * | * |
| 16-17 | 280 | 203 | * | * | * | 136 |
| NO SUBSTANCE USE DISORDER1 | 4,168 | 3,901 | 1,235 | 1,167 | 2,933 | 2,734 |
| 12-13 | 982 | 912 | 198 | 212 | 785 | 700 |
| 14-15 | 1,446 | 1,566 | 492 | 440 | 954 | 1,126 |
| 16-17 | 1,739a | 1,423 | 545 | 516 | 1,195a | 908 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Substance Use Disorder Status/Age Group | Total (2021) |
Total (2022) |
Male (2021) |
Male (2022) |
Female (2021) |
Female (2022) |
|---|---|---|---|---|---|---|
| SUBSTANCE USE DISORDER1 | 44.5 | 43.1 | 31.5 | 30.1 | 54.2 | 53.3 |
| 12-13 | * | * | * | * | * | * |
| 14-15 | 44.7 | 43.7 | 20.8 | 21.6 | 59.2 | 60.6 |
| 16-17 | 43.3 | 43.7 | * | 36.1 | 50.9 | 49.8 |
| Drug Use Disorder1 | 43.5 | 44.2 | 31.8 | 30.6 | 53.2 | 55.6 |
| 12-13 | * | * | * | * | * | * |
| 14-15 | 44.8 | 44.0 | * | * | * | * |
| 16-17 | 43.0 | 46.6 | * | 38.5 | 49.6 | 53.1 |
| Alcohol Use Disorder | 54.3 | 46.1 | * | * | 60.6 | 52.9 |
| 12-13 | * | * | * | * | * | * |
| 14-15 | * | * | * | * | * | * |
| 16-17 | 55.7 | 45.9 | * | * | * | 51.8 |
| NO SUBSTANCE USE DISORDER1 | 18.4 | 17.3 | 10.4 | 10.0 | 27.2 | 25.2 |
| 12-13 | 12.2 | 12.0 | 4.7 | 5.5 | 20.5 | 18.6 |
| 14-15 | 19.2 | 19.4 | 12.1 | 10.3 | 27.5 | 29.8 |
| 16-17 | 24.6a | 20.6 | 15.2 | 14.3 | 34.2a | 27.5 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Substance Use Disorder Status/Age Group | Total (2021) |
Total (2022) |
Male (2021) |
Male (2022) |
Female (2021) |
Female (2022) |
|---|---|---|---|---|---|---|
| SUBSTANCE USE DISORDER1 | 781 | 750 | 199 | 199 | 582 | 551 |
| 12-13 | * | * | * | * | * | * |
| 14-15 | 269 | 271 | 47 | 54 | 222 | 218 |
| 16-17 | 406 | 400 | 130 | 121 | 276 | 279 |
| Drug Use Disorder1 | 617 | 639 | 173 | 180 | 443 | 460 |
| 12-13 | * | 59 | * | * | * | * |
| 14-15 | 201 | 239 | 39 | * | * | * |
| 16-17 | 334 | 341 | * | 105 | 220 | 236 |
| Alcohol Use Disorder | 387 | 279 | * | 66 | 292 | 213 |
| 12-13 | * | * | * | * | * | * |
| 14-15 | * | * | * | * | * | * |
| 16-17 | 200 | 171 | * | * | * | 121 |
| NO SUBSTANCE USE DISORDER1 | 2,991 | 2,845 | 848 | 797 | 2,143 | 2,048 |
| 12-13 | 681 | 639 | 117 | 136 | 564 | 503 |
| 14-15 | 1,077 | 1,148 | 335 | 327 | 741 | 821 |
| 16-17 | 1,233 | 1,059 | 396 | 335 | 838 | 724 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Substance Use Disorder Status/Age Group | Total (2021) |
Total (2022) |
Male (2021) |
Male (2022) |
Female (2021) |
Female (2022) |
|---|---|---|---|---|---|---|
| SUBSTANCE USE DISORDER1 | 34.3 | 35.2 | 20.3 | 21.1 | 44.8 | 46.6 |
| 12-13 | * | * | * | * | * | * |
| 14-15 | 39.1 | 37.6 | 18.1 | 17.1 | 51.7 | 53.5 |
| 16-17 | 31.4 | 35.8 | 21.7 | 24.4 | 39.7 | 44.8 |
| Drug Use Disorder1 | 34.3 | 37.0 | 21.2 | 22.8 | 45.2 | 49.0 |
| 12-13 | * | 26.0 | * | * | * | * |
| 14-15 | 39.8 | 38.6 | 18.1 | * | * | * |
| 16-17 | 31.3 | 38.7 | * | 26.9 | 39.5 | 48.3 |
| Alcohol Use Disorder | 41.9 | 38.0 | * | 23.8 | 47.9 | 46.5 |
| 12-13 | * | * | * | * | * | * |
| 14-15 | * | * | * | * | * | * |
| 16-17 | 40.4 | 38.6 | * | * | * | 46.1 |
| NO SUBSTANCE USE DISORDER1 | 13.2 | 12.6 | 7.2 | 6.8 | 19.9 | 18.9 |
| 12-13 | 8.5 | 8.4 | 2.8 | 3.5 | 14.9 | 13.4 |
| 14-15 | 14.3 | 14.2 | 8.2 | 7.6 | 21.4 | 21.8 |
| 16-17 | 17.5 | 15.4 | 11.1 | 9.3 | 24.0 | 22.0 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| MDE Status/ Demographic Characteristic |
SUBSTANCE USE DISORDER STATUS | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No Substance Use Disorder1 |
No Substance Use Disorder1 |
Substance Use Disorder | ||||||||||||
| Drugs1 | Drugs1 | Marijuana | Marijuana | Opioids1 | Opioids1 | Alcohol | Alcohol | Both Drugs and Alcohol1 |
Both Drugs and Alcohol1 |
Drugs or Alcohol1 |
Drugs or Alcohol1 |
|||
| 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | |
| TOTAL2 | 23,615 | 23,498 | 1,896 | 1,813 | 1,348 | 1,308 | 275 | 265 | 965a | 753 | 458 | 338 | 2,404 | 2,228 |
| MDE | 4,168 | 3,901 | 782 | 769 | 549 | 542 | 135 | 90 | 506a | 339 | 270 | 185 | 1,018 | 922 |
| Age Group | ||||||||||||||
| 12-13 | 982 | 912 | 98 | 86 | 32 | 35 | 51 | 22 | 60 | 50 | 11 | 17 | 147 | 119 |
| 14-15 | 1,446 | 1,566 | 227 | 273 | 151 | 186 | 42 | 37 | 166a | 85 | 84 | 43 | 308 | 315 |
| 16-17 | 1,739a | 1,423 | 458 | 410 | 365 | 321 | 42 | 31 | 280 | 203 | 175 | 125 | 563 | 488 |
| Gender | ||||||||||||||
| Male | 1,235 | 1,167 | 261 | 241 | 203 | 176 | 43 | 22 | 133 | 96 | 84 | 52 | 310 | 285 |
| Female | 2,933 | 2,734 | 522 | 528 | 346 | 366 | 92 | 67 | 373a | 243 | 186 | 133 | 708 | 637 |
| MDE with Severe Impairment |
2,991 | 2,845 | 617 | 639 | 423 | 448 | 119 | 81 | 387 | 279 | 223 | 168 | 781 | 750 |
| Age Group | ||||||||||||||
| 12-13 | 681 | 639 | 82 | 59 | 32 | 15 | 36 | 20 | 35 | 36 | 11 | 16 | 106 | 80 |
| 14-15 | 1,077 | 1,148 | 201 | 239 | 132 | 163 | 42 | 36 | 152a | 72 | 84 | 40 | 269 | 271 |
| 16-17 | 1,233 | 1,059 | 334 | 341 | 260 | 270 | 41 | 25 | 200 | 171 | 128 | 112 | 406 | 400 |
| Gender | ||||||||||||||
| Male | 848 | 797 | 173 | 180 | 144 | 129 | 31 | 22 | 96 | 66 | 69 | 46 | 199 | 199 |
| Female | 2,143 | 2,048 | 443 | 460 | 279 | 319 | 88 | 59 | 292 | 213 | 153 | 122 | 582 | 551 |
| NO MDE | 18,476 | 18,661 | 1,017 | 969 | 739 | 721 | 128 | 165 | 426 | 397 | 171 | 147 | 1,272 | 1,218 |
| Age Group | ||||||||||||||
| 12-13 | 7,054 | 6,688 | 131 | 151 | 48 | 59 | 35 | 58 | 62 | 42 | 38 | 10 | 155 | 183 |
| 14-15 | 6,089 | 6,497 | 279 | 348 | 191 | 252 | 32 | 60 | 141 | 115 | 40 | 56 | 380 | 407 |
| 16-17 | 5,333 | 5,477 | 607 | 470 | 500 | 410 | 61 | 47 | 223 | 240 | 93 | 81 | 737 | 629 |
| Gender | ||||||||||||||
| Male | 10,613 | 10,562 | 559 | 547 | 417 | 399 | 45 | 81 | 183 | 180 | 67 | 67 | 675 | 661 |
| Female | 7,863 | 8,100 | 459 | 422 | 322 | 322 | 83 | 84 | 243 | 216 | 104 | 81 | 597 | 558 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. 2 The Total row includes respondents with unknown past year MDE information. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||||||
| MDE Status/ Demographic Characteristic |
SUBSTANCE USE DISORDER STATUS | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No Substance Use Disorder1 |
No Substance Use Disorder1 |
Substance Use Disorder | ||||||||||||
| Drugs1 | Drugs1 | Marijuana | Marijuana | Opioids1 | Opioids1 | Alcohol | Alcohol | Both Drugs and Alcohol1 |
Both Drugs and Alcohol1 |
Drugs or Alcohol1 |
Drugs or Alcohol1 |
|||
| 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | |
| TOTAL2 | 90.8 | 91.3 | 7.3 | 7.0 | 5.2 | 5.1 | 1.1 | 1.0 | 3.7a | 2.9 | 1.8 | 1.3 | 9.2 | 8.7 |
| MDE | 80.4 | 80.9 | 15.1 | 15.9 | 10.6 | 11.2 | 2.6 | 1.9 | 9.7a | 7.0 | 5.2 | 3.8 | 19.6 | 19.1 |
| Age Group | ||||||||||||||
| 12-13 | 87.0 | 88.5 | 8.7 | 8.3 | 2.9 | 3.4 | 4.5 | 2.2 | 5.3 | 4.9 | 0.9 | 1.7 | 13.0 | 11.5 |
| 14-15 | 82.4 | 83.2 | 12.9 | 14.5 | 8.6 | 9.9 | 2.4 | 1.9 | 9.5a | 4.5 | 4.8 | 2.3 | 17.6 | 16.8 |
| 16-17 | 75.6 | 74.5 | 19.9 | 21.5 | 15.9 | 16.8 | 1.8 | 1.6 | 12.1 | 10.6 | 7.6 | 6.6 | 24.4 | 25.5 |
| Gender | ||||||||||||||
| Male | 79.9 | 80.4 | 16.9 | 16.6 | 13.1 | 12.2 | 2.8 | 1.5 | 8.6 | 6.6 | 5.4 | 3.6 | 20.1 | 19.6 |
| Female | 80.6 | 81.1 | 14.3 | 15.7 | 9.5 | 10.9 | 2.5 | 2.0 | 10.2 | 7.2 | 5.1 | 4.0 | 19.4 | 18.9 |
| MDE with Severe Impairment |
79.3 | 79.1 | 16.3 | 17.8 | 11.2 | 12.5 | 3.2 | 2.2 | 10.3 | 7.8 | 5.9 | 4.7 | 20.7 | 20.9 |
| Age Group | ||||||||||||||
| 12-13 | 86.5 | 88.9 | 10.4 | 8.2 | 4.0 | 2.1 | 4.6 | 2.7 | 4.5 | 5.1 | 1.4 | 2.2 | 13.5 | 11.1 |
| 14-15 | 80.0 | 80.9 | 14.9 | 16.9 | 9.8 | 11.5 | 3.1 | 2.5 | 11.3a | 5.1 | 6.2 | 2.8 | 20.0 | 19.1 |
| 16-17 | 75.2 | 72.6 | 20.4 | 23.4 | 15.9 | 18.5 | 2.5 | 1.7 | 12.2 | 11.7 | 7.8 | 7.7 | 24.8 | 27.4 |
| Gender | ||||||||||||||
| Male | 81.0 | 80.0 | 16.5 | 18.0 | 13.7 | 12.9 | 2.9 | 2.2 | 9.1 | 6.6 | 6.6 | 4.6 | 19.0 | 20.0 |
| Female | 78.6 | 78.8 | 16.3 | 17.7 | 10.3 | 12.3 | 3.2 | 2.3 | 10.7 | 8.2 | 5.6 | 4.7 | 21.4 | 21.2 |
| NO MDE | 93.6 | 93.9 | 5.2 | 4.9 | 3.7 | 3.6 | 0.6 | 0.8 | 2.2 | 2.0 | 0.9 | 0.7 | 6.4 | 6.1 |
| Age Group | ||||||||||||||
| 12-13 | 97.8 | 97.3 | 1.8 | 2.2 | 0.7 | 0.9 | 0.5 | 0.8 | 0.9 | 0.6 | 0.5 | 0.1 | 2.2 | 2.7 |
| 14-15 | 94.1 | 94.1 | 4.3 | 5.0 | 3.0 | 3.6 | 0.5 | 0.9 | 2.2 | 1.7 | 0.6 | 0.8 | 5.9 | 5.9 |
| 16-17 | 87.9 | 89.7 | 10.0 | 7.7 | 8.2 | 6.7 | 1.0 | 0.8 | 3.7 | 3.9 | 1.5 | 1.3 | 12.1 | 10.3 |
| Gender | ||||||||||||||
| Male | 94.0 | 94.1 | 4.9 | 4.9 | 3.7 | 3.6 | 0.4 | 0.7 | 1.6 | 1.6 | 0.6 | 0.6 | 6.0 | 5.9 |
| Female | 92.9 | 93.6 | 5.4 | 4.9 | 3.8 | 3.7 | 1.0 | 1.0 | 2.9 | 2.5 | 1.2 | 0.9 | 7.1 | 6.4 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. 2 The Total row includes respondents with unknown past year MDE information. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||||||
| Substance Use Disorder and MDE | Total (2021) |
Total (2022) |
Male (2021) |
Male (2022) |
Female (2021) |
Female (2022) |
|---|---|---|---|---|---|---|
| Substance Use Disorder and MDE1 | 1,018 | 922 | 310 | 285 | 708 | 637 |
| Substance Use Disorder and MDE with Severe Impairment1 | 781 | 750 | 199 | 199 | 582 | 551 |
| Drug Use Disorder and MDE1 | 782 | 769 | 261 | 241 | 522 | 528 |
| Drug Use Disorder and MDE with Severe Impairment1 | 617 | 639 | 173 | 180 | 443 | 460 |
| Alcohol Use Disorder and MDE | 506a | 339 | 133 | 96 | 373a | 243 |
| Alcohol Use Disorder and MDE with Severe Impairment | 387 | 279 | 96 | 66 | 292 | 213 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Substance Use Disorder and MDE | Total (2021) |
Total (2022) |
Male (2021) |
Male (2022) |
Female (2021) |
Female (2022) |
|---|---|---|---|---|---|---|
| Substance Use Disorder and MDE1 | 4.1 | 3.7 | 2.4 | 2.2 | 5.9 | 5.3 |
| Substance Use Disorder and MDE with Severe Impairment1 | 3.1 | 3.0 | 1.6 | 1.6 | 4.8 | 4.6 |
| Drug Use Disorder and MDE1 | 3.1 | 3.1 | 2.0 | 1.9 | 4.3 | 4.4 |
| Drug Use Disorder and MDE with Severe Impairment1 | 2.5 | 2.6 | 1.4 | 1.4 | 3.7 | 3.8 |
| Alcohol Use Disorder and MDE | 2.0a | 1.4 | 1.0 | 0.8 | 3.1a | 2.0 |
| Alcohol Use Disorder and MDE with Severe Impairment | 1.6 | 1.1 | 0.7 | 0.5 | 2.4 | 1.8 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. NOTE: Respondents with unknown impairment data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Substance Use Disorder Severity Level | Aged 12-17 (2021) |
Aged 12-17 (2022) |
Had MDE1 (2021) |
Had MDE1 (2022) |
Had MDE with Severe Impairment1,2 (2021) |
Had MDE with Severe Impairment1,2 (2022) |
No MDE1 (2021) |
No MDE1 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | 26,019 | 25,726 | 5,186 | 4,823 | 3,773 | 3,595 | 19,748 | 19,880 |
| Substance Use Disorder3 | 2,404 | 2,228 | 1,018 | 922 | 781 | 750 | 1,272 | 1,218 |
| Mild SUD | 1,326 | 1,195 | 517 | 424 | 384 | 326 | 748 | 741 |
| Moderate SUD | 612 | 547 | 260 | 220 | 198 | 177 | 323 | 310 |
| Severe SUD | 466 | 486 | 241 | 278 | 199 | 247 | 202 | 167 |
| No SUD | 23,615 | 23,498 | 4,168 | 3,901 | 2,991 | 2,845 | 18,476 | 18,661 |
| Drug Use Disorder3 | 1,896 | 1,813 | 782 | 769 | 617 | 639 | 1,017 | 969 |
| Mild SUD | 994 | 894 | 391 | 325 | 291 | 261 | 557 | 548 |
| Moderate SUD | 508 | 464 | 201 | 180 | 159 | 144 | 277 | 268 |
| Severe SUD | 394 | 454 | 191 | 263 | 166 | 235 | 183 | 152 |
| No SUD | 24,123 | 23,913 | 4,404 | 4,055 | 3,156 | 2,956 | 18,731 | 18,911 |
| Marijuana Use Disorder | 1,348 | 1,308 | 549 | 542 | 423 | 448 | 739 | 721 |
| Mild SUD | 599 | 569 | 225 | 194 | 164 | 157 | 345 | 362 |
| Moderate SUD | 445 | 374 | 184 | 134 | 142 | 104 | 238 | 226 |
| Severe SUD | 304 | 365 | 140 | 214 | 118 | 188 | 155 | 133 |
| No SUD | 24,671a | 24,418 | 4,637 | 4,281 | 3,349 | 3,147 | 19,010 | 19,159 |
| Opioid Use Disorder3 | 275 | 265 | 135 | 90 | 119 | 81 | 128 | 165 |
| Mild SUD | 183 | 189 | 78 | 55 | 63 | 46 | 101 | 132 |
| Moderate SUD | 33 | 38 | 18 | 14 | 18 | 14 | 6 | 21 |
| Severe SUD | 60 | 39 | 39 | 21 | 38 | 21 | 21 | 12 |
| No SUD | 25,744b | 25,461 | 5,051 | 4,733 | 3,653 | 3,515 | 19,620 | 19,714 |
| Alcohol Use Disorder | 965a | 753 | 506a | 339 | 387 | 279 | 426 | 397 |
| Mild SUD | 677a | 498 | 340a | 202 | 259 | 154 | 313 | 284 |
| Moderate SUD | 180 | 184 | 100 | 98 | 81 | 91 | 79 | 82 |
| Severe SUD | 108 | 71 | 65 | 39 | 48 | 34 | 34 | 30 |
| No SUD | 25,054 | 24,972 | 4,681 | 4,484 | 3,385 | 3,316 | 19,322 | 19,483 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 2 Respondents with unknown impairment data were excluded. 3 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance Use Disorder Severity Level | Aged 12-17 (2021) |
Aged 12-17 (2022) |
Had MDE1 (2021) |
Had MDE1 (2022) |
Had MDE with Severe Impairment1,2 (2021) |
Had MDE with Severe Impairment1,2 (2022) |
No MDE1 (2021) |
No MDE1 (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Substance Use Disorder3 | 9.2 | 8.7 | 19.6 | 19.1 | 20.7 | 20.9 | 6.4 | 6.1 |
| Mild SUD | 5.1 | 4.6 | 10.0 | 8.8 | 10.2 | 9.1 | 3.8 | 3.7 |
| Moderate SUD | 2.4 | 2.1 | 5.0 | 4.6 | 5.3 | 4.9 | 1.6 | 1.6 |
| Severe SUD | 1.8 | 1.9 | 4.6 | 5.8 | 5.3 | 6.9 | 1.0 | 0.8 |
| No SUD | 90.8 | 91.3 | 80.4 | 80.9 | 79.3 | 79.1 | 93.6 | 93.9 |
| Drug Use Disorder3 | 7.3 | 7.0 | 15.1 | 15.9 | 16.3 | 17.8 | 5.2 | 4.9 |
| Mild SUD | 3.8 | 3.5 | 7.5 | 6.7 | 7.7 | 7.2 | 2.8 | 2.8 |
| Moderate SUD | 2.0 | 1.8 | 3.9 | 3.7 | 4.2 | 4.0 | 1.4 | 1.4 |
| Severe SUD | 1.5 | 1.8 | 3.7a | 5.5 | 4.4 | 6.5 | 0.9 | 0.8 |
| No SUD | 92.7 | 93.0 | 84.9 | 84.1 | 83.7 | 82.2 | 94.8 | 95.1 |
| Marijuana Use Disorder | 5.2 | 5.1 | 10.6 | 11.2 | 11.2 | 12.5 | 3.7 | 3.6 |
| Mild SUD | 2.3 | 2.2 | 4.3 | 4.0 | 4.3 | 4.4 | 1.7 | 1.8 |
| Moderate SUD | 1.7 | 1.5 | 3.5 | 2.8 | 3.8 | 2.9 | 1.2 | 1.1 |
| Severe SUD | 1.2 | 1.4 | 2.7a | 4.4 | 3.1a | 5.2 | 0.8 | 0.7 |
| No SUD | 94.8 | 94.9 | 89.4 | 88.8 | 88.8 | 87.5 | 96.3 | 96.4 |
| Opioid Use Disorder3 | 1.1 | 1.0 | 2.6 | 1.9 | 3.2 | 2.2 | 0.6 | 0.8 |
| Mild SUD | 0.7 | 0.7 | 1.5 | 1.1 | 1.7 | 1.3 | 0.5 | 0.7 |
| Moderate SUD | 0.1 | 0.1 | 0.3 | 0.3 | 0.5 | 0.4 | 0.0 | 0.1 |
| Severe SUD | 0.2 | 0.2 | 0.8 | 0.4 | 1.0 | 0.6 | 0.1 | 0.1 |
| No SUD | 98.9 | 99.0 | 97.4 | 98.1 | 96.8 | 97.8 | 99.4 | 99.2 |
| Alcohol Use Disorder | 3.7a | 2.9 | 9.7a | 7.0 | 10.3 | 7.8 | 2.2 | 2.0 |
| Mild SUD | 2.6a | 1.9 | 6.6a | 4.2 | 6.9 | 4.3 | 1.6 | 1.4 |
| Moderate SUD | 0.7 | 0.7 | 1.9 | 2.0 | 2.1 | 2.5 | 0.4 | 0.4 |
| Severe SUD | 0.4 | 0.3 | 1.3 | 0.8 | 1.3 | 0.9 | 0.2 | 0.2 |
| No SUD | 96.3a | 97.1 | 90.3a | 93.0 | 89.7 | 92.2 | 97.8 | 98.0 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 2 Respondents with unknown impairment data were excluded. 3 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance Use Disorder Status/MDE Status/Age Group |
Received Substance Use Treatment (SU Tx) OR Mental Health (MH) Treatment (2021) |
Received Substance Use Treatment (SU Tx) OR Mental Health (MH) Treatment (2022) |
Received SU Tx BUT NOT MH Treatment (2021) |
Received SU Tx BUT NOT MH Treatment (2022) |
Received MH Treatment BUT NOT SU Tx (2021) |
Received MH Treatment BUT NOT SU Tx (2022) |
Received SU Tx AND MH Treatment (2021) |
Received SU Tx AND MH Treatment (2022) |
Received NEITHER SU Tx NOR MH Treatment (2021) |
Received NEITHER SU Tx NOR MH Treatment (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| Substance Use Disorder and MDE |
-- | 660 | -- | 14 | -- | 454 | -- | 192 | -- | 262 |
| 12-13 | -- | * | -- | * | -- | * | -- | * | -- | * |
| 14-15 | -- | 237 | -- | 3 | -- | 154 | -- | 80 | -- | 78 |
| 16-17 | -- | 353 | -- | * | -- | 244 | -- | 97 | -- | 135 |
| Substance Use Disorder and MDE with Severe Impairment1 |
-- | 557 | -- | 14 | -- | 380 | -- | 163 | -- | 194 |
| 12-13 | -- | * | -- | * | -- | * | -- | * | -- | * |
| 14-15 | -- | * | -- | 3 | -- | * | -- | * | -- | * |
| 16-17 | -- | 299 | -- | * | -- | 212 | -- | 76 | -- | 101 |
| Substance Use Disorder and No MDE |
-- | 465 | -- | 79 | -- | 233 | -- | 154 | -- | 753 |
| 12-13 | -- | * | -- | * | -- | * | -- | * | -- | * |
| 14-15 | -- | 160 | -- | * | -- | * | -- | 37 | -- | 247 |
| 16-17 | -- | 203 | -- | 15 | -- | 126 | -- | 63 | -- | 426 |
| MDE and No Substance Use Disorder |
-- | 2,144 | -- | 49 | -- | 1,883 | -- | 211 | -- | 1,758 |
| 12-13 | -- | 538 | -- | 16 | -- | 479 | -- | 44 | -- | 373 |
| 14-15 | -- | 871 | -- | 21 | -- | 750 | -- | 100 | -- | 695 |
| 16-17 | -- | 734 | -- | 12 | -- | 654 | -- | 68 | -- | 689 |
| No Substance Use Disorder and No MDE |
-- | 4,397 | -- | 181 | -- | 3,969 | -- | 246 | -- | 14,265 |
| 12-13 | -- | 1,720 | -- | 46 | -- | 1,588 | -- | 87 | -- | 4,968 |
| 14-15 | -- | 1,544 | -- | 83 | -- | 1,365 | -- | 95 | -- | 4,953 |
| 16-17 | -- | 1,133 | -- | 52 | -- | 1,016 | -- | 64 | -- | 4,345 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received at prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment. NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 1 Respondents with unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance Use Disorder Status/MDE Status/Age Group |
Received Substance Use Treatment (SU Tx) OR Mental Health (MH) Treatment (2021) |
Received Substance Use Treatment (SU Tx) OR Mental Health (MH) Treatment (2022) |
Received SU Tx BUT NOT MH Treatment (2021) |
Received SU Tx BUT NOT MH Treatment (2022) |
Received MH Treatment BUT NOT SU Tx (2021) |
Received MH Treatment BUT NOT SU Tx (2022) |
Received SU Tx AND MH Treatment (2021) |
Received SU Tx AND MH Treatment (2022) |
Received NEITHER SU Tx NOR MH Treatment (2021) |
Received NEITHER SU Tx NOR MH Treatment (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| Substance Use Disorder and MDE |
-- | 71.6 | -- | 1.5 | -- | 49.3 | -- | 20.8 | -- | 28.4 |
| 12-13 | -- | * | -- | * | -- | * | -- | * | -- | * |
| 14-15 | -- | 75.1 | -- | 0.9 | -- | 48.9 | -- | 25.3 | -- | 24.9 |
| 16-17 | -- | 72.3 | -- | * | -- | 50.1 | -- | 19.9 | -- | 27.7 |
| Substance Use Disorder and MDE with Severe Impairment1 |
-- | 74.2 | -- | 1.8 | -- | 50.6 | -- | 21.7 | -- | 25.8 |
| 12-13 | -- | * | -- | * | -- | * | -- | * | -- | * |
| 14-15 | -- | * | -- | 1.1 | -- | * | -- | * | -- | * |
| 16-17 | -- | 74.8 | -- | * | -- | 53.1 | -- | 19.1 | -- | 25.2 |
| Substance Use Disorder and No MDE |
-- | 38.2 | -- | 6.5 | -- | 19.1 | -- | 12.6 | -- | 61.8 |
| 12-13 | -- | * | -- | * | -- | * | -- | * | -- | * |
| 14-15 | -- | 39.2 | -- | * | -- | * | -- | 9.1 | -- | 60.8 |
| 16-17 | -- | 32.3 | -- | 2.3 | -- | 20.0 | -- | 10.0 | -- | 67.7 |
| MDE and No Substance Use Disorder |
-- | 54.9 | -- | 1.3 | -- | 48.3 | -- | 5.4 | -- | 45.1 |
| 12-13 | -- | 59.1 | -- | 1.7 | -- | 52.6 | -- | 4.8 | -- | 40.9 |
| 14-15 | -- | 55.6 | -- | 1.4 | -- | 47.9 | -- | 6.4 | -- | 44.4 |
| 16-17 | -- | 51.6 | -- | 0.8 | -- | 46.0 | -- | 4.8 | -- | 48.4 |
| No Substance Use Disorder and No MDE |
-- | 23.6 | -- | 1.0 | -- | 21.3 | -- | 1.3 | -- | 76.4 |
| 12-13 | -- | 25.7 | -- | 0.7 | -- | 23.7 | -- | 1.3 | -- | 74.3 |
| 14-15 | -- | 23.8 | -- | 1.3 | -- | 21.0 | -- | 1.5 | -- | 76.2 |
| 16-17 | -- | 20.7 | -- | 1.0 | -- | 18.6 | -- | 1.2 | -- | 79.3 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received at prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment. NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded. 1 Respondents with unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | HAD SERIOUS THOUGHTS OF SUICIDE | |||||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | Not Sure/Don’t Know | Don’t Want to Answer/Refuse |
|||||
| 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | |
| TOTAL | 3,355 | 3,427 | 18,004 | 18,347 | 2,149 | 1,911 | 2,419b | 1,909 |
| AGE GROUP | ||||||||
| 12-13 | 894 | 790 | 6,213 | 6,243 | 701 | 631 | 1,009b | 722 |
| 14-15 | 1,149a | 1,389 | 5,906 | 6,303 | 731 | 661 | 725 | 671 |
| 16-17 | 1,312 | 1,248 | 5,884 | 5,801 | 718 | 619 | 685a | 517 |
| GENDER | ||||||||
| Male | 1,112 | 1,151 | 10,438 | 10,540 | 891a | 701 | 783 | 673 |
| Female | 2,244 | 2,277 | 7,565 | 7,807 | 1,258 | 1,210 | 1,636b | 1,236 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 2,512 | 2,596 | 13,529 | 13,578 | 1,558 | 1,451 | 1,686b | 1,351 |
| AIAN | * | 18 | * | 158 | * | 17 | * | 26 |
| Asian | 164 | 197 | 986 | 1,138 | 166 | 156 | 127 | 108 |
| Black or African American | 410 | 425 | 2,588 | 2,510 | 181 | 217 | 326 | 324 |
| NHOPI | * | * | * | * | * | * | * | * |
| White | 1,702 | 1,820 | 9,232 | 9,166 | 1,126 | 985 | 1,052a | 811 |
| Two or More Races | 156 | 127 | 559 | 560 | 66 | 71 | 109 | 76 |
| Hispanic or Latino | 843 | 832 | 4,475a | 4,769 | 592 | 461 | 733a | 558 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | HAD SERIOUS THOUGHTS OF SUICIDE | |||||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | Not Sure/Don’t Know | Don’t Want to Answer/Refuse |
|||||
| 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | |
| TOTAL | 12.9 | 13.4 | 69.4a | 71.7 | 8.3 | 7.5 | 9.3b | 7.5 |
| AGE GROUP | ||||||||
| 12-13 | 10.1 | 9.4 | 70.5a | 74.4 | 7.9 | 7.5 | 11.4b | 8.6 |
| 14-15 | 13.5 | 15.4 | 69.4 | 69.9 | 8.6 | 7.3 | 8.5 | 7.4 |
| 16-17 | 15.3 | 15.3 | 68.4 | 70.9 | 8.3 | 7.6 | 8.0 | 6.3 |
| GENDER | ||||||||
| Male | 8.4 | 8.8 | 78.9 | 80.7 | 6.7 | 5.4 | 5.9 | 5.1 |
| Female | 17.7 | 18.2 | 59.6a | 62.3 | 9.9 | 9.7 | 12.9b | 9.9 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 13.0 | 13.7 | 70.2 | 71.6 | 8.1 | 7.6 | 8.7b | 7.1 |
| AIAN | * | 8.2 | * | 72.3 | * | 7.8 | * | 11.7 |
| Asian | 11.4 | 12.3 | 68.3 | 71.2 | 11.5 | 9.7 | 8.8 | 6.8 |
| Black or African American | 11.7 | 12.2 | 73.8 | 72.2 | 5.2 | 6.3 | 9.3 | 9.3 |
| NHOPI | * | * | * | * | * | * | * | * |
| White | 13.0 | 14.2 | 70.4 | 71.7 | 8.6 | 7.7 | 8.0a | 6.3 |
| Two or More Races | 17.5 | 15.2 | 62.7 | 67.1 | 7.4 | 8.5 | 12.3 | 9.2 |
| Hispanic or Latino | 12.7 | 12.6 | 67.4a | 72.0 | 8.9 | 7.0 | 11.0a | 8.4 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | MADE ANY SUICIDE PLANS | |||||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | Not Sure/Don’t Know | Don’t Want to Answer/Refuse |
|||||
| 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | |
| TOTAL | 1,604 | 1,666 | 21,294 | 21,372 | 1,019 | 864 | 2,009a | 1,692 |
| AGE GROUP | ||||||||
| 12-13 | 472 | 436 | 7,245 | 7,113 | 303 | 248 | 797a | 590 |
| 14-15 | 558 | 664 | 6,948 | 7,396 | 382 | 337 | 622 | 627 |
| 16-17 | 575 | 567 | 7,101 | 6,864 | 334 | 279 | 589 | 476 |
| GENDER | ||||||||
| Male | 470 | 461 | 11,710 | 11,694 | 369 | 340 | 675 | 571 |
| Female | 1,134 | 1,206 | 9,585 | 9,678 | 650 | 524 | 1,334 | 1,121 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 1,119 | 1,291 | 16,030 | 15,873 | 733 | 586 | 1,404 | 1,226 |
| AIAN | * | * | * | 172 | * | 10 | 14 | 25 |
| Asian | 71 | 80 | 1,243 | 1,342 | 64 | 55 | 65 | 123 |
| Black or African American | 191 | 262 | 2,910 | 2,824 | 133 | 114 | 270 | 276 |
| NHOPI | * | * | * | * | * | * | * | * |
| White | 764 | 874 | 10,952 | 10,816 | 461 | 365 | 935a | 729 |
| Two or More Races | 39 | 57 | 715 | 668 | 66 | 40 | 71 | 69 |
| Hispanic or Latino | 486 | 375 | 5,265a | 5,500 | 286 | 278 | 605 | 466 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | MADE ANY SUICIDE PLANS | |||||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | Not Sure/Don’t Know | Don’t Want to Answer/Refuse |
|||||
| 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | |
| TOTAL | 6.2 | 6.5 | 82.1 | 83.5 | 3.9 | 3.4 | 7.7a | 6.6 |
| AGE GROUP | ||||||||
| 12-13 | 5.3 | 5.2 | 82.2 | 84.8 | 3.4 | 3.0 | 9.0a | 7.0 |
| 14-15 | 6.6 | 7.4 | 81.6 | 82.0 | 4.5 | 3.7 | 7.3 | 6.9 |
| 16-17 | 6.7 | 6.9 | 82.6 | 83.9 | 3.9 | 3.4 | 6.9 | 5.8 |
| GENDER | ||||||||
| Male | 3.6 | 3.5 | 88.6 | 89.5 | 2.8 | 2.6 | 5.1 | 4.4 |
| Female | 8.9 | 9.6 | 75.5 | 77.2 | 5.1 | 4.2 | 10.5 | 8.9 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 5.8 | 6.8 | 83.1 | 83.6 | 3.8 | 3.1 | 7.3 | 6.5 |
| AIAN | * | * | * | 78.9 | * | 4.5 | 8.6 | 11.5 |
| Asian | 4.9 | 5.0 | 86.2 | 83.9 | 4.4 | 3.4 | 4.5 | 7.7 |
| Black or African American | 5.4 | 7.5 | 83.0 | 81.2 | 3.8 | 3.3 | 7.7 | 7.9 |
| NHOPI | * | * | * | * | * | * | * | * |
| White | 5.8 | 6.8 | 83.5 | 84.6 | 3.5 | 2.9 | 7.1a | 5.7 |
| Two or More Races | 4.4 | 6.8 | 80.2 | 80.2 | 7.5 | 4.8 | 7.9 | 8.3 |
| Hispanic or Latino | 7.3 | 5.7 | 79.3a | 83.1 | 4.3 | 4.2 | 9.1 | 7.0 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | ATTEMPTED SUICIDE | |||||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | Not Sure/Don’t Know | Don’t Want to Answer/Refuse |
|||||
| 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | |
| TOTAL | 940 | 953 | 22,802 | 22,589 | 529 | 553 | 1,656 | 1,500 |
| AGE GROUP | ||||||||
| 12-13 | 315 | 256 | 7,614 | 7,378 | 223 | 197 | 665 | 556 |
| 14-15 | 326 | 397 | 7,491 | 7,900 | 166 | 206 | 528 | 520 |
| 16-17 | 299 | 300 | 7,698 | 7,311 | 140 | 150 | 463 | 424 |
| GENDER | ||||||||
| Male | 316 | 295 | 12,165 | 12,087 | 152 | 205 | 590 | 479 |
| Female | 623 | 658 | 10,638 | 10,502 | 377 | 349 | 1,066 | 1,021 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 646 | 703 | 17,199b | 16,767 | 342 | 413 | 1,097 | 1,093 |
| AIAN | * | 5 | * | 173 | 1 | * | * | 37 |
| Asian | 44 | 41 | 1,285 | 1,397 | 31 | 53 | 84 | 108 |
| Black or African American | 141 | 164 | 3,060 | 2,974 | 88 | 96 | 215 | 242 |
| NHOPI | * | * | * | * | * | * | * | * |
| White | 403 | 437 | 11,851 | 11,468 | 197 | 236 | 661 | 643 |
| Two or More Races | 26 | 48 | 772 | 704 | 25 | 23 | 68 | 58 |
| Hispanic or Latino | 294 | 250 | 5,603a | 5,822 | 187 | 140 | 559a | 408 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | ATTEMPTED SUICIDE | |||||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | Not Sure/Don’t Know | Don’t Want to Answer/Refuse |
|||||
| 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | |
| TOTAL | 3.6 | 3.7 | 87.9 | 88.3 | 2.0 | 2.2 | 6.4 | 5.9 |
| AGE GROUP | ||||||||
| 12-13 | 3.6 | 3.0 | 86.4 | 88.0 | 2.5 | 2.4 | 7.5 | 6.6 |
| 14-15 | 3.8 | 4.4 | 88.0 | 87.5 | 1.9 | 2.3 | 6.2 | 5.8 |
| 16-17 | 3.5 | 3.7 | 89.5 | 89.3 | 1.6 | 1.8 | 5.4 | 5.2 |
| GENDER | ||||||||
| Male | 2.4 | 2.3 | 92.0 | 92.5 | 1.2 | 1.6 | 4.5 | 3.7 |
| Female | 4.9 | 5.3 | 83.7 | 83.8 | 3.0 | 2.8 | 8.4 | 8.2 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 3.4 | 3.7 | 89.2 | 88.4 | 1.8 | 2.2 | 5.7 | 5.8 |
| AIAN | * | 2.3 | * | 79.2 | 0.4 | * | * | 16.8 |
| Asian | 3.0 | 2.6 | 89.0 | 87.3 | 2.2 | 3.3 | 5.8 | 6.8 |
| Black or African American | 4.0 | 4.7 | 87.3 | 85.5 | 2.5 | 2.8 | 6.1 | 7.0 |
| NHOPI | * | * | * | * | * | * | * | * |
| White | 3.1 | 3.4 | 90.4 | 89.7 | 1.5 | 1.9 | 5.0 | 5.0 |
| Two or More Races | 2.9 | 5.8 | 86.7 | 84.5 | 2.8 | 2.7 | 7.7 | 7.0 |
| Hispanic or Latino | 4.4 | 3.8 | 84.4a | 88.0 | 2.8 | 2.1 | 8.4a | 6.2 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | HAD SERIOUS THOUGHTS OF SUICIDE, MADE ANY SUICIDE PLANS, OR ATTEMPTED SUICIDE |
|||||
|---|---|---|---|---|---|---|
| Any of These Suicidality Measures |
None of These Suicidality Measures |
Unknown | ||||
| 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | |
| TOTAL | 3,506 | 3,596 | 17,759 | 18,160 | 4,662b | 3,839 |
| AGE GROUP | ||||||
| 12-13 | 944 | 844 | 6,118 | 6,167 | 1,755b | 1,375 |
| 14-15 | 1,209a | 1,448 | 5,826 | 6,252 | 1,475 | 1,323 |
| 16-17 | 1,352 | 1,304 | 5,815 | 5,741 | 1,432a | 1,141 |
| GENDER | ||||||
| Male | 1,177 | 1,188 | 10,326 | 10,431 | 1,720a | 1,446 |
| Female | 2,329 | 2,408 | 7,433 | 7,729 | 2,942b | 2,394 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 2,613 | 2,722 | 13,336 | 13,446 | 3,336b | 2,808 |
| AIAN | * | 21 | * | 152 | * | 46 |
| Asian | 168 | 199 | 979 | 1,117 | 296 | 284 |
| Black or African American | 432 | 471 | 2,517 | 2,480 | 556 | 526 |
| NHOPI | * | * | * | * | * | * |
| White | 1,774 | 1,887 | 9,126 | 9,106 | 2,212b | 1,791 |
| Two or More Races | 158 | 136 | 550 | 545 | 182 | 152 |
| Hispanic or Latino | 893 | 874 | 4,423a | 4,713 | 1,326b | 1,032 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: The “Any of These Suicidality Measures” category includes respondents with one or more “yes” responses to suicidal thoughts, plans, or attempts, regardless of whether they had one or more unknown responses for these measures. The “None of These Suicidality Measures” category includes respondents with “no” responses to all three measures. The “Unknown” category includes respondents who did not respond “yes” to any of the three suicidality questions and who responded “not sure/don’t know” or “don’t want to answer/refuse” to any of the three suicidality questions. Respondents with unknown suicide data other than these categories were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Demographic Characteristic | HAD SERIOUS THOUGHTS OF SUICIDE, MADE ANY SUICIDE PLANS, OR ATTEMPTED SUICIDE |
|||||
|---|---|---|---|---|---|---|
| Any of These Suicidality Measures |
None of These Suicidality Measures |
Unknown | ||||
| 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | |
| TOTAL | 13.5 | 14.1 | 68.5b | 70.9 | 18.0b | 15.0 |
| AGE GROUP | ||||||
| 12-13 | 10.7 | 10.1 | 69.4a | 73.5 | 19.9a | 16.4 |
| 14-15 | 14.2 | 16.0 | 68.5 | 69.3 | 17.3a | 14.7 |
| 16-17 | 15.7 | 15.9 | 67.6 | 70.1 | 16.7a | 13.9 |
| GENDER | ||||||
| Male | 8.9 | 9.1 | 78.1 | 79.8 | 13.0a | 11.1 |
| Female | 18.3 | 19.2 | 58.5a | 61.7 | 23.2b | 19.1 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 13.5 | 14.3 | 69.2 | 70.9 | 17.3b | 14.8 |
| AIAN | * | 9.7 | * | 69.4 | * | 20.9 |
| Asian | 11.6 | 12.4 | 67.8 | 69.8 | 20.5 | 17.7 |
| Black or African American | 12.3 | 13.5 | 71.8 | 71.3 | 15.9 | 15.1 |
| NHOPI | * | * | * | * | * | * |
| White | 13.5 | 14.8 | 69.6 | 71.2 | 16.9b | 14.0 |
| Two or More Races | 17.8 | 16.4 | 61.8 | 65.4 | 20.4 | 18.3 |
| Hispanic or Latino | 13.4 | 13.2 | 66.6a | 71.2 | 20.0b | 15.6 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: The “Any of These Suicidality Measures” category includes respondents with one or more “yes” responses to suicidal thoughts, plans, or attempts, regardless of whether they had one or more unknown responses for these measures. The “None of These Suicidality Measures” category includes respondents with “no” responses to all three measures. The “Unknown” category includes respondents who did not respond “yes” to any of the three suicidality questions and who responded “not sure/don’t know” or “don’t want to answer/refuse” to any of the three suicidality questions. Respondents with unknown suicide data other than these categories were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Past Year Mental Health or Substance Use Measure | HAD SERIOUS THOUGHTS OF SUICIDE | |||||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | Not Sure/Don’t Know | Don’t Want to Answer/Refuse |
|||||
| 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | |
| MAJOR DEPRESSIVE EPISODE STATUS | ||||||||
| Major Depressive Episode | 2,288 | 2,241 | 1,318 | 1,235 | 669 | 693 | 910b | 654 |
| No Major Depressive Episode | 980 | 1,138 | 16,326 | 16,720 | 1,235 | 1,020 | 1,193a | 956 |
| MENTAL HEALTH TREATMENT AND SOUGHT OR THOUGHT SHOULD GET TREATMENT STATUS |
||||||||
| Mental Health Treatment1 | -- | 2,034 | -- | 4,084 | -- | 716 | -- | 802 |
| No Mental Health Treatment1 | -- | 1,394 | -- | 14,263 | -- | 1,195 | -- | 1,107 |
| Sought or Thought Should Get Treatment2 | -- | 733 | -- | 868 | -- | 347 | -- | 256 |
| Did Not Seek Treatment and Did Not Think Should Get Treatment2 | -- | 640 | -- | 13,231 | -- | 815 | -- | 774 |
| SUBTANCE USE DISORDER STATUS | ||||||||
| Substance Use Disorder3 | 831 | 748 | 1,089 | 955 | 196 | 284 | 276 | 206 |
| Alcohol Use Disorder4 | 395a | 266 | 353 | 311 | 94 | 107 | 123 | 63 |
| Drug Use Disorder3 | 661 | 635 | 875 | 744 | 142a | 228 | 208 | 178 |
| No Substance Use Disorder3 | 2,524 | 2,680 | 16,914 | 17,392 | 1,953a | 1,628 | 2,143b | 1,703 |
| SUBSTANCE USE TREATMENT STATUS | ||||||||
| Substance Use Treatment5,6 | -- | 390 | -- | 515 | -- | 105 | -- | 163 |
| No Substance Use Treatment5,6 | -- | 3,038 | -- | 17,832 | -- | 1,807 | -- | 1,746 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. 2 Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. 3 Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. 4 Alcohol use disorder (AUD) estimates are based on DSM-5 criteria. 5 Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received at prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. 6 Because of the proportion of respondents in the “substance unspecified” category for treatment, these estimates have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Past Year Mental Health or Substance Use Measure | HAD SERIOUS THOUGHTS OF SUICIDE | |||||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | Not Sure/Don’t Know | Don’t Want to Answer/Refuse |
|||||
| 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | |
| MAJOR DEPRESSIVE EPISODE STATUS | ||||||||
| Major Depressive Episode | 44.1 | 46.5 | 25.4 | 25.6 | 12.9 | 14.4 | 17.6a | 13.6 |
| No Major Depressive Episode | 5.0 | 5.7 | 82.7 | 84.3 | 6.3a | 5.1 | 6.0a | 4.8 |
| MENTAL HEALTH TREATMENT AND SOUGHT OR THOUGHT SHOULD GET TREATMENT STATUS |
||||||||
| Mental Health Treatment1 | -- | 26.6 | -- | 53.5 | -- | 9.4 | -- | 10.5 |
| No Mental Health Treatment1 | -- | 7.8 | -- | 79.4 | -- | 6.7 | -- | 6.2 |
| Sought or Thought Should Get Treatment2 | -- | 33.3 | -- | 39.4 | -- | 15.8 | -- | 11.6 |
| Did Not Seek Treatment and Did Not Think Should Get Treatment2 | -- | 4.1 | -- | 85.6 | -- | 5.3 | -- | 5.0 |
| SUBTANCE USE DISORDER STATUS | ||||||||
| Substance Use Disorder3 | 34.7 | 34.1 | 45.5 | 43.6 | 8.2a | 12.9 | 11.5 | 9.4 |
| Alcohol Use Disorder4 | 40.9 | 35.6 | 36.6 | 41.6 | 9.7 | 14.4 | 12.8 | 8.4 |
| Drug Use Disorder3 | 35.0 | 35.6 | 46.4 | 41.7 | 7.5a | 12.8 | 11.0 | 10.0 |
| No Substance Use Disorder3 | 10.7 | 11.5 | 71.9a | 74.3 | 8.3a | 7.0 | 9.1b | 7.3 |
| SUBSTANCE USE TREATMENT STATUS | ||||||||
| Substance Use Treatment5,6 | -- | 33.2 | -- | 43.9 | -- | 8.9 | -- | 13.9 |
| No Substance Use Treatment5,6 | -- | 12.4 | -- | 73.0 | -- | 7.4 | -- | 7.1 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. 2 Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. 3 Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. 4 Alcohol use disorder (AUD) estimates are based on DSM-5 criteria. 5 Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received at prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. 6 Because of the proportion of respondents in the “substance unspecified” category for treatment, these estimates have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Past Year Mental Health or Substance Use Measure | MADE ANY SUICIDE PLANS | |||||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | Not Sure/Don’t Know | Don’t Want to Answer/Refuse |
|||||
| 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | |
| MAJOR DEPRESSIVE EPISODE STATUS | ||||||||
| Major Depressive Episode | 1,191 | 1,199 | 2,750 | 2,577 | 407 | 390 | 839 | 658 |
| No Major Depressive Episode | 375 | 443 | 18,022 | 18,265 | 448 | 354 | 889 | 771 |
| MENTAL HEALTH TREATMENT AND SOUGHT OR THOUGHT SHOULD GET TREATMENT STATUS |
||||||||
| Mental Health Treatment1 | -- | 1,087 | -- | 5,429 | -- | 395 | -- | 724 |
| No Mental Health Treatment1 | -- | 579 | -- | 15,943 | -- | 469 | -- | 968 |
| Sought or Thought Should Get Treatment2 | -- | 268 | -- | 1,547 | -- | 119 | -- | 269 |
| Did Not Seek Treatment and Did Not Think Should Get Treatment2 | -- | 294 | -- | 14,193 | -- | 333 | -- | 639 |
| SUBTANCE USE DISORDER STATUS | ||||||||
| Substance Use Disorder3 | 519 | 491 | 1,419 | 1,345 | 113 | 138 | 342a | 218 |
| Alcohol Use Disorder4 | 268a | 162 | 506 | 464 | 45 | 31 | 146 | 90 |
| Drug Use Disorder3 | 413 | 431 | 1,096 | 1,054 | 85 | 118 | 293 | 181 |
| No Substance Use Disorder3 | 1,086 | 1,175 | 19,875 | 20,027 | 906 | 726 | 1,667 | 1,474 |
| SUBSTANCE USE TREATMENT STATUS | ||||||||
| Substance Use Treatment5,6 | -- | 231 | -- | 689 | -- | 97 | -- | 156 |
| No Substance Use Treatment5,6 | -- | 1,436 | -- | 20,684 | -- | 767 | -- | 1,536 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. 2 Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. 3 Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. 4 Alcohol use disorder (AUD) estimates are based on DSM-5 criteria. 5 Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received at prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. 6 Because of the proportion of respondents in the “substance unspecified” category for treatment, these estimates have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Past Year Mental Health or Substance Use Measure | MADE ANY SUICIDE PLANS | |||||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | Not Sure/Don’t Know | Don’t Want to Answer/Refuse |
|||||
| 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | |
| MAJOR DEPRESSIVE EPISODE STATUS | ||||||||
| Major Depressive Episode | 23.0 | 24.9 | 53.0 | 53.4 | 7.8 | 8.1 | 16.2 | 13.6 |
| No Major Depressive Episode | 1.9 | 2.2 | 91.3 | 92.1 | 2.3 | 1.8 | 4.5 | 3.9 |
| MENTAL HEALTH TREATMENT AND SOUGHT OR THOUGHT SHOULD GET TREATMENT STATUS |
||||||||
| Mental Health Treatment1 | -- | 14.2 | -- | 71.1 | -- | 5.2 | -- | 9.5 |
| No Mental Health Treatment1 | -- | 3.2 | -- | 88.8 | -- | 2.6 | -- | 5.4 |
| Sought or Thought Should Get Treatment2 | -- | 12.2 | -- | 70.2 | -- | 5.4 | -- | 12.2 |
| Did Not Seek Treatment and Did Not Think Should Get Treatment2 | -- | 1.9 | -- | 91.8 | -- | 2.2 | -- | 4.1 |
| SUBTANCE USE DISORDER STATUS | ||||||||
| Substance Use Disorder3 | 21.7 | 22.4 | 59.3 | 61.4 | 4.7 | 6.3 | 14.3 | 9.9 |
| Alcohol Use Disorder4 | 27.8 | 21.7 | 52.4 | 62.2 | 4.7 | 4.1 | 15.1 | 12.0 |
| Drug Use Disorder3 | 21.9 | 24.2 | 58.1 | 59.1 | 4.5 | 6.6 | 15.5 | 10.2 |
| No Substance Use Disorder3 | 4.6 | 5.0 | 84.5 | 85.6 | 3.9 | 3.1 | 7.1 | 6.3 |
| SUBSTANCE USE TREATMENT STATUS | ||||||||
| Substance Use Treatment5,6 | -- | 19.7 | -- | 58.7 | -- | 8.3 | -- | 13.3 |
| No Substance Use Treatment5,6 | -- | 5.9 | -- | 84.7 | -- | 3.1 | -- | 6.3 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. 2 Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. 3 Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. 4 Alcohol use disorder (AUD) estimates are based on DSM-5 criteria. 5 Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received at prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. 6 Because of the proportion of respondents in the “substance unspecified” category for treatment, these estimates have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Past Year Mental Health or Substance Use Measure | ATTEMPTED SUICIDE | |||||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | Not Sure/Don’t Know | Don’t Want to Answer/Refuse |
|||||
| 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | |
| MAJOR DEPRESSIVE EPISODE STATUS | ||||||||
| Major Depressive Episode | 668 | 663 | 3,580 | 3,325 | 183 | 256 | 756a | 580 |
| No Major Depressive Episode | 260 | 279 | 18,601 | 18,690 | 230 | 201 | 644 | 664 |
| MENTAL HEALTH TREATMENT AND SOUGHT OR THOUGHT SHOULD GET TREATMENT STATUS |
||||||||
| Mental Health Treatment1 | -- | 619 | -- | 6,100 | -- | 265 | -- | 652 |
| No Mental Health Treatment1 | -- | 334 | -- | 16,489 | -- | 288 | -- | 848 |
| Sought or Thought Should Get Treatment2 | -- | 120 | -- | 1,797 | -- | 84 | -- | 202 |
| Did Not Seek Treatment and Did Not Think Should Get Treatment2 | -- | 201 | -- | 14,463 | -- | 193 | -- | 603 |
| SUBTANCE USE DISORDER STATUS | ||||||||
| Substance Use Disorder3 | 335 | 397 | 1,657 | 1,479 | 94 | 88 | 306 | 228 |
| Alcohol Use Disorder4 | 182 | 124 | 614 | 514 | 49 | 23 | 119 | 86 |
| Drug Use Disorder3 | 274 | 354 | 1,276 | 1,171 | 71 | 73 | 265 | 186 |
| No Substance Use Disorder3 | 605 | 556 | 21,145 | 21,109 | 434 | 465 | 1,350 | 1,272 |
| SUBSTANCE USE TREATMENT STATUS | ||||||||
| Substance Use Treatment5,6 | -- | 163 | -- | 816 | -- | 51 | -- | 142 |
| No Substance Use Treatment5,6 | -- | 790 | -- | 21,772 | -- | 502 | -- | 1,359 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. 2 Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. 3 Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. 4 Alcohol use disorder (AUD) estimates are based on DSM-5 criteria. 5 Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received at prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. 6 Because of the proportion of respondents in the “substance unspecified” category for treatment, these estimates have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Past Year Mental Health or Substance Use Measure | ATTEMPTED SUICIDE | |||||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | Not Sure/Don’t Know | Don’t Want to Answer/Refuse |
|||||
| 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2022 | |
| MAJOR DEPRESSIVE EPISODE STATUS | ||||||||
| Major Depressive Episode | 12.9 | 13.8 | 69.0 | 68.9 | 3.5a | 5.3 | 14.6 | 12.0 |
| No Major Depressive Episode | 1.3 | 1.4 | 94.3 | 94.2 | 1.2 | 1.0 | 3.3 | 3.3 |
| MENTAL HEALTH TREATMENT AND SOUGHT OR THOUGHT SHOULD GET TREATMENT STATUS |
||||||||
| Mental Health Treatment1 | -- | 8.1 | -- | 79.9 | -- | 3.5 | -- | 8.5 |
| No Mental Health Treatment1 | -- | 1.9 | -- | 91.8 | -- | 1.6 | -- | 4.7 |
| Sought or Thought Should Get Treatment2 | -- | 5.5 | -- | 81.6 | -- | 3.8 | -- | 9.2 |
| Did Not Seek Treatment and Did Not Think Should Get Treatment2 | -- | 1.3 | -- | 93.6 | -- | 1.2 | -- | 3.9 |
| SUBTANCE USE DISORDER STATUS | ||||||||
| Substance Use Disorder3 | 14.0 | 18.1 | 69.3 | 67.5 | 3.9 | 4.0 | 12.8 | 10.4 |
| Alcohol Use Disorder4 | 18.8 | 16.7 | 63.7 | 68.8 | 5.1 | 3.0 | 12.3 | 11.5 |
| Drug Use Disorder3 | 14.5 | 19.8 | 67.7 | 65.6 | 3.8 | 4.1 | 14.0 | 10.5 |
| No Substance Use Disorder3 | 2.6 | 2.4 | 89.8 | 90.2 | 1.8 | 2.0 | 5.7 | 5.4 |
| SUBSTANCE USE TREATMENT STATUS | ||||||||
| Substance Use Treatment5,6 | -- | 13.9 | -- | 69.6 | -- | 4.4 | -- | 12.1 |
| No Substance Use Treatment5,6 | -- | 3.2 | -- | 89.1 | -- | 2.1 | -- | 5.6 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. 2 Respondents with unknown information for whether they sought or thought they should get mental health treatment were excluded. 3 Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. 4 Alcohol use disorder (AUD) estimates are based on DSM-5 criteria. 5 Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received at prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. 6 Because of the proportion of respondents in the “substance unspecified” category for treatment, these estimates have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Suicidal Behavior/Treatment for Suicide Attempt |
Aged 12-17 (2021) |
Aged 12-17 (2022) |
Aged 12-13 (2021) |
Aged 12-13 (2022) |
Aged 14-15 (2021) |
Aged 14-15 (2022) |
Aged 16-17 (2021) |
Aged 16-17 (2022) |
Male (2021) |
Male (2022) |
Female (2021) |
Female (2022) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ATTEMPTED SUICIDE | ||||||||||||
| Yes | 940 | 953 | 315 | 256 | 326 | 397 | 299 | 300 | 316 | 295 | 623 | 658 |
| No | 22,802 | 22,589 | 7,614 | 7,378 | 7,491 | 7,900 | 7,698 | 7,311 | 12,165 | 12,087 | 10,638 | 10,502 |
| Not Sure/Don’t Know | 529 | 553 | 223 | 197 | 166 | 206 | 140 | 150 | 152 | 205 | 377 | 349 |
| Don’t Want to Answer/Refuse | 1,656 | 1,500 | 665 | 556 | 528 | 520 | 463 | 424 | 590 | 479 | 1,066 | 1,021 |
| RECEIVED MEDICAL ATTENTION FOR SUICIDE ATTEMPT AMONG PEOPLE WHO ATTEMPTED SUICIDE |
||||||||||||
| Yes | 305 | 340 | * | * | * | 159 | * | 101 | * | * | 183 | 251 |
| No | 570 | 561 | * | * | 198 | 220 | * | 183 | * | * | 395 | 373 |
| Not Sure/Don’t Know | 33 | 30 | * | 11 | 6 | * | * | * | 7 | * | 26 | 17 |
| Don’t Want to Answer/Refuse | 31 | 23 | 15 | 8 | 9 | * | * | * | * | * | 20 | 17 |
| STAYED OVERNIGHT OR LONGER IN A HOSPITAL FOR SUICIDE ATTEMPT AMONG PEOPLE WHO ATTEMPTED SUICIDE |
||||||||||||
| Yes | 170 | 176 | * | * | * | * | * | 54 | * | * | 101 | 130 |
| No | 695 | 720 | * | * | * | * | * | 229 | * | * | 476 | 490 |
| Not Sure/Don’t Know | 1 | 0 | 1 | 0 | * | * | * | * | * | 0 | 1 | * |
| Don’t Want to Answer/Refuse | * | 4 | * | * | * | 3 | 0 | * | * | * | 0 | 4 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||||
| Suicidal Behavior/Treatment for Suicide Attempt |
Aged 12-17 (2021) |
Aged 12-17 (2022) |
Aged 12-13 (2021) |
Aged 12-13 (2022) |
Aged 14-15 (2021) |
Aged 14-15 (2022) |
Aged 16-17 (2021) |
Aged 16-17 (2022) |
Male (2021) |
Male (2022) |
Female (2021) |
Female (2022) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ATTEMPTED SUICIDE | ||||||||||||
| Yes | 3.6 | 3.7 | 3.6 | 3.0 | 3.8 | 4.4 | 3.5 | 3.7 | 2.4 | 2.3 | 4.9 | 5.3 |
| No | 87.9 | 88.3 | 86.4 | 88.0 | 88.0 | 87.5 | 89.5 | 89.3 | 92.0 | 92.5 | 83.7 | 83.8 |
| Not Sure/Don’t Know | 2.0 | 2.2 | 2.5 | 2.4 | 1.9 | 2.3 | 1.6 | 1.8 | 1.2 | 1.6 | 3.0 | 2.8 |
| Don’t Want to Answer/Refuse | 6.4 | 5.9 | 7.5 | 6.6 | 6.2 | 5.8 | 5.4 | 5.2 | 4.5 | 3.7 | 8.4 | 8.2 |
| RECEIVED MEDICAL ATTENTION FOR SUICIDE ATTEMPT AMONG PEOPLE WHO ATTEMPTED SUICIDE |
||||||||||||
| Yes | 32.5 | 35.7 | * | * | * | 40.2 | * | 33.6 | * | * | 29.3 | 38.2 |
| No | 60.7 | 58.8 | * | * | 60.8 | 55.5 | * | 61.0 | * | * | 63.4 | 56.6 |
| Not Sure/Don’t Know | 3.5 | 3.1 | * | 4.1 | 1.9 | * | * | * | 2.3 | * | 4.2 | 2.5 |
| Don’t Want to Answer/Refuse | 3.3 | 2.4 | 4.7 | 3.3 | 2.7 | * | * | * | * | * | 3.2 | 2.6 |
| STAYED OVERNIGHT OR LONGER IN A HOSPITAL FOR SUICIDE ATTEMPT AMONG PEOPLE WHO ATTEMPTED SUICIDE |
||||||||||||
| Yes | 19.4 | 19.5 | * | * | * | * | * | 19.1 | * | * | 17.4 | 20.8 |
| No | 79.4 | 80.0 | * | * | * | * | * | 80.4 | * | * | 82.4 | 78.6 |
| Not Sure/Don’t Know | 0.1 | 0.0 | 0.3 | 0.1 | * | * | * | * | * | 0.1 | 0.1 | * |
| Don’t Want to Answer/Refuse | * | 0.5 | * | * | * | 0.7 | 0.2 | * | * | * | 0.1 | 0.7 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||||
